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ABSTRACT

SYNTHESIS OF THIOACIDS AND DICARBOXYLIC ACIDS DERIVED FROM OPEN
-LACTAMS FOR INHIBITION OF METALLO-β-LACTAMASES

By
JUNFU CHEN
University of New Hampshire, December 2021
Antibiotics are important substances that have been used in clinical treatment for
over 70 years. Because of overuse and misuse of antibiotics, bacteria developed resistance.
However, bacterial resistance towards antibiotics, especially the β-lactam antibiotics, is
becoming increasingly threat. Currently, the β-lactam antibiotics are seriously threatened by
β-lactamases. Metallo-β-lactamases (MBLs), a sub-class of β-lactamases, have been found in
several bacteria since they confer resistance to many different β-lactams, and as a result, the
bacteria survive in their presence. A potential treatment is to synthesize inhibitors of MBLs,
however, there are no inhibitors synthesized in clinical use. The goal of this project is to
synthesize a series of thioacids and dicarboxylic acids derived from open β-lactams, which
are proposed to work as inhibitors of MBLs. Both might show inhibition due to their strong
binding to the active site zinc ions in MBLs using a "sulfide/hydroxyl release" strategy. If
active, these compounds would prevent the enzymes from hydrolyzing β-lactam antibiotic
drugs.
The synthesis of thioacids was attempted through two routes. The initial synthesis

xx

involved thio-lactam formation using Lawesson’s reagent, followed by thio-lactam ring
opening under basic conditions. An alternative method that was attempted utilized β-lactam
ring opening under basic conditions followed by thionation of the resulting carboxylic acid.
However, the thionation step was challenging when attempted on the highly-functionalized
intermediates in both synthetic routes.
The synthesis of the dicarboxylic acids was overall successful in 5 steps from
commercially available penicillin derived starting material. The successfully synthesized
targets may provide a new type of MBL inhibitor. This research also broadened the substrate
scope of β-lactam ring opening under basic conditions, which could provide access to other
β-lactam-derived enzyme inhibitors in the future.

xxi

Chapter 1-Introduction of Bacterial Threats, Antibiotics and Resistance

1.1 Bacteria and Their Threats to Human Beings
Microbes, also known as microorganisms, are wide spread in our world. According
to current research, there are around one trillion kinds of microorganisms all over the world.1
There are six major types of microorganisms: bacteria, archaea, fungi, protozoa, algae, and
viruses. Bacteria, an important type of microorganism, are found everywhere in the world:
soil, rocks, oceans, and even arctic ice. Bacteria play several important roles in our daily lives.
Some bacteria that live in the soil can participate in the cycling of nutrients. They can degrade
dead plants or animals, turn them into chemical nutrients, and release them back into the
environment. Bacteria also comprise a huge part of our body: there are approximately ten
times as many bacterial cells as human cells in the human body.2 Bacteria are found on the
skin, mouth, gut, etc. They are a part of the human microbiome and live in harmony with
their human hosts, providing vital functions essential for human survival.3 These bacteria are
very helpful and necessary for our body, and are regarded as "good bacteria".

However, not all bacteria are beneficial to us. Some "bad bacteria" can infect our
cells, reproduce, and emit some toxins that cause damage. Many infectious diseases are
caused by bacteria; for example, pertussis is caused by the bacterium Bordetella pertussis.4
People who are infected by B. pertussis develop a cough, have difficulty breathing, and even
die in severe cases. According to a recent analysis, in 2015 there were around 16.3 million
pertussis cases all over the world, and 58,700 deaths as a result.5 Scientists are working hard

1

to find out some medicine for diseases caused by bacteria, and finally, antibiotics come into
sight.

1.2 The Use of Antibiotics
Antibiotics are medicines that fight infections caused by bacteria in humans and
animals by either killing the bacteria or making it difficult for the bacteria to grow and
reproduce. When discussing antibiotics, a very important term, antibiosis, is introduced.
Antibiosis is a biological interaction between two or more organisms that is detrimental to at
least one of them, which means one organism can be affected by another by releasing a
metabolic substance.6 Until the late 1920s, with the help of previous work, Sir Alexander
Fleming discovered the antibiotic penicillin. By accident, a culture plate of Staphylococcus
was contaminated by Penicillium notatum, and he found that the colonies of the
Staphylococcus, which in contact with the mold of Penicillium notatum, were destroyed.
After that, Penicillin G (Figure 1) was isolated, and has been used as antibiotic for a long
time.7

Figure 1. Penicillin G.

There are now over 100 different known kinds of antibiotics. Based on their different
modes of action, they can be divided into 5 types: (1) agents that inhibit synthesis of nucleic
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acids (DNA & RNA) (e.g. fluoroquinolones); (2) agents that inhibit important metabolic
pathways of the bacteria (e.g. sulfonamides); (3) agents that inhibit protein synthesis by
affecting the function of 30S or 50S ribosomal subunits (e.g. aminoglycosides); (4) agents
that interfere with the plasma membrane of the bacteria, affecting permeability (e.g.
polymyxins); (5) agents that inhibit synthesis of the bacterial cell wall (β-lactam antibiotics,
e.g. penicillins and cephalosporins; glycopeptides).8 (Figure 2)

Figure 2. Antibiotics classified based on their bacterial target.9

Some kinds of compounds such as fluoroquinolones (Figure 3) can disrupt the
synthesis of DNA and RNA. The disruption of nucleic acid synthesis is detrimental to the
survival and growth of bacterial cells. Fluoroquinolones target both DNA gyrase and
topoisomerase IV in different bacteria and inhibit their control of supercoiling within the cell;
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and this affects DNA replication (at lower concentrations) or leads to cell death (at lethal
concentrations).10

Figure 3. Ciprofloxacin, a second-generation fluoroquinolone.

The second type of antibiotics comprises agents that inhibit important metabolic
pathways of the bacteria. For example, an important metabolic pathway is the formation of
folic acid. Folic acid is essential for growth of all cells. Compared to mammalian cells, folic
acid cannot cross bacterial cell walls by simple diffusion or transportation. Folic acid is
therefore synthesized in the bacteria from the substrates p-aminobenzoic acid (PABA) and
dihydropterin pyrophosphate (DHPP) with the first step catalyzed by dihydropteroate
synthase (DHPS). The sulfonamide competes with PABA in the active site of DHPS to
inhibit the formation of folic acid at the very first step (Scheme 1).11
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Scheme 1. Comparison of the reaction catalyzed by dihydropteroate synthase (DHPS)
between PABA and p-aminosulfonamide in the early step of the formation of folic acid.11

The third type of antibiotics comprises agents that inhibit protein synthesis by
affecting the function of the 30S or 50S ribosomal subunits. There are 3 steps of protein
synthesis in the bacteria: (1) Initiation begins with the formation of an initiation complex with
the small ribosome subunit (30S) and messenger ribonucleic acid (mRNA); and transfer
ribonucleic acid (tRNA) brings the first amino acid in the polypeptide chain to bind to the
start codon (AUG) on mRNA. At this point, the large ribosomal subunit (50S) then binds to
the initiation complex for the coming elongation step. (2) Elongation step: during the
elongation process, tRNAs bring amino acids one by one to the peptide chain. (3)
Termination step: when a particular mRNA sequence (stop codon, UAG) occurs, the whole
process stops, and the recycling step is the release of the peptide chain from the ribosomes,
which are ready to bind to another mRNA chain to start a new protein synthesis cycle.12
(Figure 4)
5

Figure 4. Protein synthesis in bacteria.12

To inhibit the synthesis of proteins, there are four major types of antibiotics: (1)
Antibiotics such as tetracyclines can bind to the 30S ribosomal subunit to prevent initiation;
(2) Streptomycin, a kind of aminoglycoside, interferes with codon recognition and
translocation by binding to the bacterial decoding site; (3) Linezolid, a kind of oxazolidinone,
targets the peptidyl transferase center (PTC) on the 50S subunit to prevent peptide bond
formation; (4) Erythromycin, a kind of macrolide, blocks the growth of the peptide chain at
the peptide exit tunnel (Figure 5).12
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Figure 5. Four known antibiotics that inhibit protein synthesis.

The fourth type of antibiotic interferes with the plasma membrane of bacteria. The
bacterial plasma membrane has three major functions: (1) it inhibits toxic substances from
entering into the bacterial cell; (2) it contains membrane proteins that allow specific
molecules, such as nutrients, which participate in cellular and extracellular activities, to
transport between organelles in the cell or between the cells and the outside environment; (3)
it affords a separate environment for organelles to process their own metabolic functions.13
Bacterial cells cannot survive when their membrane structure is broken down. For example,
polymyxins (Figure 6) are antibiotics that interact with phospholipids and disrupt the
structure of the plasma membrane. Polymyxins especially bind to the lipids and
lipopolysaccharide (LPS) on the outer membrane of Gram-negative bacteria; and disrupt both
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inner and outer membranes, leading to disintegration of bacterial cell membrane.14

Figure 6. Polymyxin B2.

The last type of antibiotics is agent that inhibits the synthesis of the bacterial cell
wall. Cell walls are necessary for bacteria to maintain cell integrity and shape. They can also
protect the cell against mechanical and osmotic stress, and allow cells to develop turgor
pressure. Without the protection of cell walls, bacterial cells would lyse from too much
pressure.15 Bacterial cell wall synthesis is a complex process, catalyzed by several different
proteins. One of the most important proteins is known as the penicillin binding proteins
(PBPs). PBPs in the cell wall catalyze cross-link formation between adjacent glycan chains,
and cross-linked glycan chains lead to cell wall synthesis and extension (Figure 7).16
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Figure 7. β-lactam antibiotics mechanism of action.17 Glycosyltransferases (GT) links
m-DAP and D-Ala, so that PBPs could catalyze cross-link between glycan chains. β-Lactam
antibiotics bind to the active site of PBPs to prevent cross-linking during cell wall synthesis.

Very popular types of antibiotics are the β-lactam antibiotics, which interrupt
peptidoglycan synthesis by inhibiting PBP activity, leading to bacterial cell lysis and death
(Figure 7). β-Lactam antibiotics are the most widely used group of antibiotics, accounting for
~65% of the total world market.18 Since human cells do not contain cell walls, β-lactam
antibiotics do not affect human cells, so they are widely used to treat bacterial infections.
There are four major types of β-lactam antibiotics: penicillins, cephalosporins, carbapenems,
and monobactams (Figure 8).19
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Figure 8. Four kinds of β-lactam antibiotics.

1.3 Antibiotic resistance in bacteria
When bacteria experience difficulty, they might show or develop resistance. There are
two major types of resistance: natural resistance and acquired resistance. The natural
resistance is observed without exposure to antibiotics or some other harmful microbes.20
There are two types of natural resistance: intrinsic resistance and induced resistance. Intrinsic
resistance can be regarded as an inherent part of the bacteria. It is very common to find some
specific large molecules on the outer membrane which can control transportation, for
example, lipopolysaccharide (LPS). LPS is a large molecule composed of lipid and
polysaccharides containing O-antigen, outer core, and inner core connected by covalent
bonds. Lipopolysaccharide is the main component of the outer membrane of gram-negative
bacteria. It provides and maintains the integrity of the bacterial structure and protects the
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bacterial cell membrane against attack by certain chemical substances (e.g. antibiotics).21

The other type of natural resistance is called induced resistance. Bacteria contain
some specific genes that are not expressed under normal environmental conditions. However,
when the bacteria are exposed to something harmful (e.g. antibiotics), they will upregulate
expression of these genes such that resistance will be manifested. An example of this is a
multidrug resistance efflux pump.22

Acquired resistance is the most common type of resistance in bacteria. It occurs
when a bacterial cell acquires the ability to resist the activity of a harmful substance such as
an antibiotic. This may be caused by mutations of genes, or from the acquisition of
exogenous resistance genes, or the combination of these two mechanisms. Unlike intrinsic
resistance, acquired resistance is found only in certain strains or subpopulations of each
specific bacterial species. Acquired resistance results from mutation and/or exchanges, and it
can be divided into two parts: vertical gene transfer (VGT) and horizontal gene transfer
(HGT).23

Vertical gene transfer is the transfer of genetic material from parents to offspring.
When exposed to some antibiotics, the bacteria may develop resistance as a result of a
random mutation in the DNA sequence within the gene. During reproduction, this mutated
gene will be transferred to the offspring rendering it resistant to specific antimicrobials.
Horizontal gene transfer is the transfer between unrelated bacteria. Many antibiotic resistance
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genes are carried on plasmids, transposons, or integrons that can act as vectors that transfer
these genes to other members of the same bacterial species, as well as to bacteria in another
species.24

Mechanisms of Antibiotic Resistance in bacteria
Usually, the genetic mutations caused by acquired resistance gives bacteria the
ability to exhibit four possible mechanisms of antibiotic resistance: (1) prevention of access
to targets (decreased influx and/or increase efflux); (2) changes in antibiotic targets by
mutation; (3) protection of targets (target site alterations); (4) direct modification of
antibiotics (e.g. antibiotic inactivating enzyme).25

Prevention of access to targets
When exposed to antibiotics, bacteria may prevent their access to targets. There are
two different methods, and the first method is to reduce the permeability. For better
explanations, the term cell envelope was introduced. The cell envelope comprises the inner
cell membrane and the cell wall of a bacterium. In Gram-negative bacteria an outer
membrane is also included.26 Compared with Gram-positive species, Gram-negative bacteria
are less permeable to many antibiotics as their outer membrane forms a permeability barrier;
also some outer membrane proteins (e.g. porins, which are water-filled channels) can also
decrease the permeability by porin deletion (Figure 9).26
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Figure 9. Comparisons of cell envelopes between Gram-positive and Gram-negative
bacteria.26 CAP: covalently attached protein; IMP: integral membrane protein; LPS:
lipopolysaccharide; LTA: lipoteichoic acid; OMP: outer membrane protein; WTA: wall
teichoic acid.

The second method is to increase the efflux.27 Efflux is a major mechanism of
resistance in Gram-negative bacteria. In bacteria, the role of efflux pumps is broad: they not
only help the bacteria survive in the presence of toxins, biocides, heavy metals, and
antimicrobial agents, but also play important roles in quorum sensing (by pumping out
quorum-sensing signal molecules), adherence, invasion, colonization of host cells, and
biofilm formation. Some efflux pumps can pump out different antimicrobials and confer
resistance to them; for some specific efflux pumps, especially in persister cells, when bacteria
are exposed to antibiotics, the rapidly dividing cells in bacteria are destroyed first. With the
help of efflux pump components, persister cells can increase efflux activity, which increases
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their tolerance to antibiotics. As a result, the persister cells could be alive and could have a
chance to mutate to show the resistance to the antibiotics in the future.28

Changes in antibiotic targets by mutation (Modification of targets)
Most antibiotics specifically bind to their targets with high affinity to prevent the
normal activity of the target. If there are any changes to the target structures that only prevent
efficient antibiotic binding without losing target function, then resistance to the antibiotic
may occur. These changes to the target structures occur at the level of the genes in bacteria,
and are called mutations.23 Because of the mutations, bacteria make modifications to the
targets at the active sites binding to antibiotics. These modifications won’t affect the
enzyme’s original function, but result in reduced affinity to the antibiotic. As a result, the
antibiotic has a reduced effect.23, 24

Protection of targets
The other type of resistance with respect to the target is called protection of target.
Antibiotic resistance in bacteria can be mediated by proteins that physically bind to the target
to protect it from the inhibitory effects of an antibiotic without losing its normal function.
Compared to the more familiar mechanism of target modification, target protection does not
involve a permanent change in the target, which means it won’t change the mutational genes
of the bacteria.29 A good example is tetracycline resistance. In Gram-positive and
Gram-negative bacteria, tetracycline binds to the 16S rRNA and inhibits the binding of the
aminoacyl-tRNA to the mRNA-ribosome complex. As a result, initiation of protein synthesis
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is inhibited. The bacteria develop resistance by synthesizing an enzyme known as a
Ribosomal Protection Protein (RPP, e.g. Tet(M)). This protein allows the aminoacyl-tRNA to
bind to the mRNA-ribosome complex in the presence of tetracycline.29

Direct modification of antibiotics
With the development of resistance, bacteria can modify the antibiotics or even
destroy them. There are two different types: (1) inactivation of antibiotics by transfer of a
chemical group; (2) inactivation of antibiotics by hydrolysis.

Inactivation of antibiotics by transfer of a chemical group
Bacteria can sometimes produce enzymes that are able to add or change different
chemical groups to antibiotics. There are lots of different groups to be used by bacteria to
modify the antibiotics: acetyl groups, phosphoryl groups, adenyl groups, etc. There are also
many enzymes found, one example being acetyltransferases. In all these modifications,
acetylation is the most widely used mechanism, and it is used against the aminoglycosides,
chloramphenicol,

the

streptogramins,

and

the

fluoroquinolones.

Chloramphenicol

acetyltransferase (CAT) is a representative example. CAT is a trimer of three subunits: Class
A CAT (Acetyl-CoA, which is shown in Figure 10), CAT-III, and Class B CAT.29 Acylation
starts with deprotonation of the nucleophilic hydroxyl group of chloramphenicol (3) by the
enzyme (2) (active site on CAT-III). After that, deprotonated chloramphenicol reacts with
Class A CAT (3) to form the acylated chloramphenicol (4), which loses its original function
as an antibiotic (Scheme 2).30
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Figure 10. Structure of Class A CAT (Acetyl-CoA) 1.

Scheme 2. Mechanism of acylation of Chloramphenicol catalyzed by chloramphenicol
acetyltransferases.29

Inactivation of antibiotics by hydrolysis
Many antibiotics have hydrolytically susceptible chemical bonds (e.g. esters and
amides), which are essential to biological activity. To confer resistance to these antibiotics,
bacteria have developed specific enzymes to destroy them by breaking these bonds. Because
these enzymes only require water to process the resistance, they can easily destroy antibiotics
before they come into contact with the bacteria.30 A very popular example is β-lactamases.

β-Lactamases
Penicillin was discovered by Sir Alexander Fleming in 1928.7 With the help of
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Fleming’s work, Abraham and Chain31 discovered the first β-lactamases in 1940, which was
earlier than the initial clinical use of penicillin in 1940s.32

Types and mechanisms of β-Lactamases
There are four types of β-lactamases: Class A, B, C, and D β-lactamases. Class A, C,
and D belong to one type of β-lactamases since they use an active site serine nucleophile to
hydrolyze the β-lactam antibiotics. Class B β-lactamases, which are also called
metallo-β-lactamases (MBLs), use active size zinc cation(s) to destroy antibiotics.33

Class A, C, and D β-lactamases
Class A, C, and D enzymes have a common feature that a catalytic serine residue
(Ser) in the active site is working as a nucleophile to mediate the hydrolysis. All of them are
using an acylation-deacylation mechanism (Scheme 3). The hydroxyl group on the serine
residue undergoes basic deprotonation, and nucleophilic attack on the carbonyl of the
β-lactam antibiotic (5) to form an acyl-enzyme intermediate 7 via tetrahedral intermediate 6.
Next, a water molecule is activated by a basic residue and undergoes nucleophilic attack on
the acyl–enzyme intermediate to achieve the diacylation tetrahedral intermediate 8. Finally,
after release of the serine residue, the ring opened lactam compound (9) loses its original
function to kill the bacteria.34
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Scheme 3. Mechanism of Class A, C, and D β-lactamases. Hydrolysis of penicillin
derivatives mediated by serine residue.34

Class B β-lactamases (Metallo-β-lactamases)
Compared to the Class A, C, and D β-lactamases, Class B β-lactamases use an active
site zinc cation(s) to coordinate to the hydroxyl group to mediate the hydrolysis. There are
three subclasses: B1, B2, and B3 (Figure 11), based on differences in the amino acid residues
at the active site that coordinate the zinc ions, and the number of zinc ions present. B1 and B3
MBLs are di-zinc species; they can hydrolyze almost all β-lactam compounds. B2 MBLs are
mono-zinc species, and they can only efficiently hydrolyze carbapenems.35, 36
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Figure 11. Some examples of B1, B2, and B3 Metallo-β-Lactamases.35

The mechanism of di-zinc species metallo-β-lactamases is as follows: The hydroxyl
group coordinated to the zinc ions of the enzyme initiates nucleophilic attack on the β-lactam
carbonyl to form a tetrahedral intermediate 10, which is stabilized by its interactions with the
zinc ions. After C-N bond cleavage (intermediate 11), by adding the water, a ring-opened
β-lactam product 12 is formed, resulting in turnover of the β-lactamase which is now capable
of another β-lactam hydrolysis cycle (Scheme 4).37
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Scheme 4. Hydrolysis of penicillin derivatives mediated by di-zinc species MBLs.37

1.4 Current Research on Inhibitors of Metallo-β-Lactamases
Compared to Class A, C, and D β-lactamases, the zinc ions in Class B β-lactamases
require different strategies for inhibitor design. There are two broad types of MBL inhibitors:
Zn-independent inhibitors and Zn-dependent inhibitors.38 Zn-independent inhibitors do not
specifically bind the zinc ions of the β-lactamases, but instead target other functional groups.
By making modifications to those functional groups, the access of β-lactamases to antibiotics
can be inhibited, so that the bacteria can be killed. The first Zn-independent MBL inhibitor
was reported by Schofield’s group in 2017.39 He found that some compounds (Figure 12)
bind adjacent to the zinc ions of VIM-2 (a Carbapenem-Hydrolyzing Metallo-β-Lactamase),
without direct zinc chelation. However, there are only few researches on Zn-independent
inhibitors.
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Figure 12. Two compounds that show inhibitory potencies against VIM-2 without direct zinc
chelations.39

The zinc ion(s) in the active site of metallo-β-lactamases is important to their
mechanism of action. Therefore, the inhibition of enzyme activity via binding of the zinc ions
could be used as another method, which has given rise to Zn-dependent inhibitors. There are
four different types: cyclic boronates,40, 41 sulfamoyl carboxylates,42, 43 dicarboxylic acids,44
and thiol-containing compounds.45, 46 (Figure 13) Those four different types of compounds
show affinity to the zinc ions. Because of the stronger coordination between zinc ions and
thiol groups, thiol derivatives could be regarded as more potent inhibitors, which gave us
ideas on inhibitor design.
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Figure 13. Four Zn-dependent inhibitors. Top Left: cyclic boronate; Top Right: sulfamoyl
compound; Bottom Left: dicarboxylic acid; Bottom Right: thiol-containing compound.

Until now, the combination of serine β-lactamase inhibitors and β-lactam antibiotics
has been shown to be of clinical use, and this method has been approved by the U.S. Food
and Drug Administration (FDA).47 Unfortunately, there are no approved inhibitors available
for MBLs. There are some challenges to develop clinical inhibitors: (1) MBLs are diverse;
there are lots of different kinds of MBLs, which have little similarities. The structural
diversity has resulted in inhibitors that are active toward only one kind of MBL but not others.
(2) The number of clinical MBLs is increasing fast these days.48 Considered these challenges
and previous research, we intended to design and synthesize a broad spectrum of MBL
inhibitor.
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Chapter 2-Synthesis of Thioacids for Inhibition of Metallo-β-Lactamases via a "Sulfide
Release" Strategy

2.1 Introduction to Thiol Research Project
Thiol-containing compounds can be used as inhibitors of metallo-β-lactamases
because of the coordination between the zinc ions and the thiol groups.49 A good example is
captopril. The better coordination between zinc ions (NDM-1, 13) and thiol groups (from
captopril 14) can lead to replacement of the hydroxyl group at the active site by a thiol group
(ternary complex 15), leading us to hypothesize that a thiol-coordinated metallo-β-lactamase
should not have the ability to hydrolyze a β-lactam antibiotic (Scheme 5).

Scheme 5. Captopril (14) shows inhibition of NDM-1 (13) through zinc ion binding.49

Tsang’s work50 gave us some ideas for inhibitor design. In his work, he found that
thioxocephalosporins (16, 20) and their hydrolyzed products (19, 22) show inhibition of some
metallo-β-lactamases (Figure 14). The thioxocephalosporin can be easily synthesized in one
step by thionations using Lawesson’s Reagent52 and the thioacid 19 can be hydrolyzed under
basic conditions (Scheme 6). In addition, if some nucleophiles (e.g. NH2) were introduced
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(thioxocephalosporin 20), the intramolecular cycloaddition products 21 could also show
strong binding between the thioamide group (via thioenol form 22) and active site zinc. The
thiol-bound enzymes (17, 18) lose their original functions to hydrolyze β-lactam rings, which
attracted our attention toward thioacid/thio-lactam inhibitors.

Figure 14. Some hydrolyzed products 17, 18 showed inhibition of metallo-β-lactamases.50

Scheme 6. Reactions of thioxocephalosporins 16 and 20 under basic conditions.50

2.2 Research Project Goal: Targets and Proposed Mechanism
We proposed to synthesize a new type of inhibitor derived from penicillin. Here, we
would like to introduce two factors into our target: a thioacid and a nucleophile. Our target is
shown in Figure 15. There are lots of advantages of our target: (1) the open β-lactam
structures have been shown to bind to MBL active sites;51 (2) thioacids have previously been
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used in MBL inhibitors to increase binding to MBL zinc ions;45 (3) nucleophiles were
introduced to the targets to increase the inhibition using sulfide release strategy.

Figure 15. Target compounds. (Nu= -OH, -NH2, -SH).

Proposed mechanism of action
The target compounds are proposed to show inhibition of β-lactamases. When the
compound interacts with an MBL active site, it can coordinate to the zinc cations with its
thiol group. After that, under physiological pH, the nucleophile on the side chain can initiate
nucleophilic attack at the thioacid carbonyl to form tetrahedral intermediate 22. After
reforming the carbonyl, cyclized compound 23 and the thiol-coordinated MBL 24 could be
released (Scheme 7).

Scheme 7. Proposed mechanism for targets by thiol-release strategy.
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2.3 Synthesis of thioacids through a Thio-Lactam Ring Opening Route
One side-chain nucleophile in which we were interested is a hydroxyl group (-OH).
The thioacid can be synthesized by basic hydrolysis of a thio-lactam 26 which can be
synthesized by thionation using Lawesson’s Reagent.52 The side chain can be added by a
Grignard reaction according to the work of Testero et al.53 (Scheme 8). Based on the previous
research in our group, we decided to use 6-aminopenicillanic acid (6-APA, 28) as the starting
material, since it is a very common penicillin derivative and it is commercially available. The
attempted synthesis of 40 is shown in Scheme 9.

Scheme 8. Retrosynthetic analysis of 25.
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Scheme 9. Attempted synthesis of the target 37. Aldehyde 31 was synthesized from 38.

The synthesis started with the bromination of 6-APA (28). It is a literature method
that uses sodium nitrite (NaNO2), liquid bromine (Br2), and hydrobromic acid (HBr) to give
dibrominated derivative 29.54 For the carboxylic acid protecting group, we chose a
diphenylmethyl (Dpm) group since it is a hindered group and it is not very base-sensitive. It
can also be easily removed under acidic conditions. To achieve this protection,
diphenyldiazomethane has been used in the past,55 but it is not commercially available. Many
diazo compounds are also toxic, irritants, and/or explosive. Instead, we decided to use a
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DCC-mediated coupling reaction to achieve the protection.56 Dibromo penicillin derivative
29 reacts with diphenylmethanol in the presence of dicyclohexylcarbodiimide (DCC) and
dimethylaminopyridine (DMAP). The reaction is mild and the yield of compound 30 is 60%.

Before achieving the addition of the side chain by a Grignard reaction, aldehyde 31
was synthesized first. A TBS group was chosen to protect the hydroxyl since it is not
base-sensitive but is removable under acidic conditions. The synthesis of aldehyde 31 is
achieved in two steps. Starting with ethylene glycol (38), the primary alcohol protection68 is
conducted by using tert-butyldimethylsilyl chloride (TBSCl) in pyridine, which acts as the
base and solvent. The yield is 65%. The next step is the oxidation of alcohol 39. In this
project, this oxidation has been investigated with two different methods: Swern oxidation or
Dess-Martin periodinane (DMP) oxidation. Swern oxidation was explored first.57 Oxalyl
chloride, dimethyl sulfoxide (DMSO), pyridine, and triethylamine were used in the reaction
at -65 oC. After aqueous workup, the product can be used without purification, and the yield
is good: 89%. When the formation of aldehyde 31 was conducted using DMP oxidation,58
compared to Swern oxidation, DMP oxidation is easier to achieve for several reasons: 1)
there is only one reagent (Dess–Martin periodinane) needed for the reaction; 2) the
temperature is 0 oC, which is easier to control than -65 oC; and 3) the workup is much easier,
since there is no need to remove DMSO and pyridine. Therefore, DMP oxidation was
ultimately chosen as the oxidation method here, even if the yield is lower at 64% (Scheme
10).
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Scheme 10. Synthesis of aldehyde 31 under Swern oxidation or DMP oxidation.

According to the work of Testero et al.,53 compound 32 was synthesized by reaction
of dibromo compound 30 with aldehyde 31 under Grignard conditions, and the yield of the
reaction was 64%. Product 32 was obtained as a mixture of two diastereomers in a ratio of
3:1, which was determined by measuring the relative integration of H5 on the β-lactam ring
(labeled in Figure 16) in the 1H NMR spectrum. To increase the yield, the reaction was
allowed to run overnight with warming to room temperature. As a result, the yield increased
from 64% to 69%.

Figure 16. Two diastereomers of product 32.

The debromination of 32 was conducted following a literature method.53 Compound
32 reacts with tri-n-butylphosphine (PBu3) and methanol (MeOH) to form compound 33. The
reaction is very efficient, and the yield is 80%. The product is a mixture of three
diastereomers, however, four diastereomers are expected, two cis and two trans. The three
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observed diastereomers consist of one cis diastereomer and two inseparable trans
diastereomers. The major products are the trans diastereomers (trans:cis = 2.3:1). The
stereochemistry was determined by measuring the coupling constant (J) between vicinal
hydrogens on the β-lactam ring (H5 and H6, which are labeled in Figure 17). In compound
33a, J = 1.8 Hz, which indicates it is a trans diastereomer, and compound 33b is determined
to be the cis diastereomer with J = 4.4 Hz. This matches the NMR data from the work of
Testero et al.53 This reaction would proceed through a tributylphosphonium β-lactam enolate
intermediate 36 (Scheme 11), and proton (from methanol) would attack the enolate from the
β-face, which could lead to the major product 33a.53

Figure 17. Two diastereomers of 35 formed after debromination.

Scheme 11. Enolate intermediate 38 formation.53

To synthesize thio-lactam compound 34, Lawesson’s reagent (LR, Figure 18) could
be a good choice. Based on Tsang’s50 and Palena’s52 work, Lawesson’s reagent can be used to
convert cephalosporins into their thio-lactam analogues, while penicillin derivatives give less
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success with lower yields. Following their procedure, compound 33 was used as the starting
material for thionation with Lawesson’s reagent. This thionation attempt gave a complex
mixture with none of desired product 34 detected.

Figure 18. Lawesson’s reagent.

Model reactions to optimize conditions for reactions with Lawesson’s reagent
To find out the best conditions for Lawesson’s reagent, at first, two simple lactams
were chosen as model compounds: 2-pyrrolidone 41 and 2-azetidinone derivative 43. The
thionation of 41 is a literature method,59 and thio-lactam product 42 was successful
synthesized, which is shown in Scheme 12.

2-Azetidinone derivative 43 was chosen since it has similar functional groups as the
penicillin starting materials 35 used in our work. To conduct this thionation, two different sets
of conditions were explored: heating to reflux in THF and heating to 90 oC in toluene.
Thio-lactam 44 was successfully synthesized in THF in 50% yield, however this thionation in
toluene failed with only starting material 43 recovered (Scheme 12).
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Scheme 12. Model reactions to synthesize 42 and 44.

To better optimize reaction conditions, starting materials that are structurally similar
to our penicillin substrates (46 and 48) were chosen for the thionation reaction. The substrate
46 can be synthesized in two steps. After a primary amine protection with a Boc group and a
carboxylic acid protection with a Bn group, compound 46 was synthesized in 50% total yield
(Scheme 13).

Scheme 13. Synthesis of penicillin derivative 46.

Substrate 48 can be synthesized from 45 with Dpm protection. Based on our
previous research, a DCC-mediated coupling was initially attempted, but a complex mixture
was collected, with none of the desired product 48 detected. However, Palena’s work48 gave
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us an alternative method wherein Dpm protection can be achieved by using
bromodiphenylmethane, tetrabutylammonium iodide (n-Bu4NI), and triethylamine in
chloroform. By using this method, benzhydryl protected compound 48 was synthesized in 59%
yield (Scheme 14).

Scheme 14. Synthesis of compound 48.

Table 1 contains a summary of results from thionation attempted using model
compounds 46 and 48 as substrates, and based on Palena’s work,48 toluene was chosen as the
solvent here (Scheme 15). Thionation was conducted with 46 first at 90 oC, but none of the
target 49 was detected (Table 1. entry 1). Thionations were then conducted with 48 at 90 oC;
longer reaction time can’t lead to formation of target 50 (Entry 2, 3, 5). An attempt to
increase the temperature to reflux doesn’t lead to 50 either (Entry 4).

Scheme 15. Model thionations with 46 and 48.
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Table 1. Conditions explored for thionation of model substrates 46 and 48.
Entry

Substrate

Temp. (oC)

Time (h)

Results

1

46

90

4

Complex mixture

2

48

90

1.5

Complex mixture

3

48

90

4

Complex mixture

4

48

Reflux

4

Complex mixture

5

48

90

16

Complex mixture

To know more about thionation of penicillin derivatives, a literature method,
synthesis of thio-lactam 54 was repeated with the same starting material 53 according to
Palena’s work.48 Synthesis of 6-methoxy-penicillate 53 is shown in Scheme 16, and
thionation of 53 was successfully conducted with Lawesson’s reagent in 16% yield.

Scheme 16. Synthesis of thio-lactam 54.

The successful thionation of compound 53, which is synthesized from diazo
compound 52 and methanol, gave us some ideas. We tried to extend this kind of research by
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using different alcohols (31, 55) to react with diazo compound 52 to synthesize potential
penicillin derivatives which could be used in thionations (Scheme 17). We initially attempted
to use the alcohols as the solvent, however, 52 is insoluble in these alcohols. When the
alcohols were used as reagents in the presence of triethylamine in different solvents (CH2Cl2,
MeCN, THF), no reactions occurred with only starting material recovered.

Scheme 17. Attempted substitution of diazo compound 52 with alcohols 31 and 55.

Thio-lactam compound 54 is also a good example to find out the conditions for basic
hydrolysis of thio-lactam rings. There is not a lot of research in this area; therefore we
decided to use lithium hydroxide (LiOH) as the base, since it may not lead to side reactions
that hydrolyze the thiazolidine ring. The thionation was conducted in CD3OD/D2O at 0 oC,
and monitored by 1H NMR. However, the product was a complex mixture and no desired
compound 58 was detected (Scheme 18).

Scheme 18. Attempted ring opening of thio-lactam 54.
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2.4 Synthesis of Thioacids through Thionation of a Carboxylic Acid
There are lots of methods to synthesize thioacids.60 Instead of hydrolysis of
thio-lactam compounds, an alternative method could be thionation of a carboxylic acid
derived from a β-lactam compound. Previously, it is a known method to use some enzymes,
such as β-lactamases, to hydrolyze the β-lactam rings biologically to form β-lactam-derived
carboxylic acids.86 However, the most challenging part in this research is to open the
β-lactam ring to form the carboxylic acid. Guan’s work61 gave us some ideas that penicillin G
could be directly hydrolyzed by aqueous strong base solution (KOH, NaOH, LiOH). With the
help of their work, desired target 80 was proposed (Figure 19).

Figure 19. Proposed target 80 as a potential MBL inhibitor.

Starting with 6-APA (28), the addition of the side chain can be achieved by
formation of an amide. The acyl group on the side chain could later be removed easily under
basic conditions. The Bn, Dpm, and PMB groups were chosen to protect the carboxylic acid
because of their stability under the basic conditions required for the ring opening reaction.
The attempted synthesis is shown in Scheme 19.
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Scheme 19. Attempted synthesis of target thioacid 80.

The synthesis started with formation of acyl chloride 61, which is shown in Scheme
20. Using the conditions described by Solovskii et al.,62 28 was allowed to react with acyl
chloride 61 in phosphate buffer (pH = 6.6) to form compound 62 in a very high yield of 90%.

Scheme 20. Synthesis of acyl chloride 61.
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There are two routes to synthesize 63 (Scheme 21). In the first route, 28 was allowed
to react with benzyl bromide to form compound 51, and 51 was then treated with acyl
chloride 61 to form compound 63, which shows a low overall yield: 16%. When the order of
the reactions is changed, where benzyl protection was conducted on 62, the overall yield
increased from 16% to 36%.

Scheme 21. Two routes to synthesize 63.

Compounds 64 and 65 are synthesized following the conditions reported by Palena
et al..48 This carboxylic acid protection was first attempted in chloroform as the solvent.
Since compound 62 is not very soluble in chloroform, the reactions were not working well
(yield of 64: 10%; 65: no reaction with starting material recovered). When acetone was
chosen as the solvent, the yield of 64 increased to 30% and 65 was successfully synthesized
in 23% yield.

There is not a lot of literature precedent on hydrolysis of β-lactam rings by using
laboratory methods. Following the conditions of Guan et al.,61 our first trial was conducted
on 63 with NaOH as the base. Considering the low solubility of 63 in water, a H2O/THF
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co-solvent mixture was used. This attempted reaction led to a complex mixture with all the
starting material being consumed, but no desired target detected (Scheme 22). There might be
three factors that lead to failure of this hydrolysis. First, this reaction may be fast at room
temperature, since a color change occurred immediately when NaOH solution was added,
indicating that a lower temperature might be needed. Second, prolonged reaction time may
lead to side reactions such as thiazolidine hydrolysis. Third, H2O/THF may not be a good
solvent system.

Scheme 22. Attempted hydrolysis of 63 with NaOH.

Ring opening was also investigated using methanol as the solvent system, which
would be expected to provide methyl esters 67-69 as the products. Several conditions were
explored to synthesize compounds 67-69 (Table 2). When NaOH was used as the base with
substrate 63, desired product 67 was isolated in 20% yield (Entry 1). LiOH and KOH were
also used as bases, with 67 isolated in 25% and 13% yields, respectively (Entries 2 and 3).
Dpm-protected compound 64 was also used as starting material. When using NaOH, KOH,
LiOH, desired product 68 could be isolated in a low yield for each of the reactions (Entries
4-6). When the reaction was run for 2 h instead of 30 min, diphenylmethanol was isolated,
which means under basic conditions, the Dpm ester is degraded after an extended time (Entry
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7).

For all these reactions, an interesting observation was made. Every time when base
was added, the color change occurred immediately. We assumed that the reaction might be
done very fast. The reaction was repeated with compound 64; after 5 min, all the starting
material had been consumed and only one product was observed, as confirmed by TLC. The
desired target 68 was isolated in 67% yield (Entry 8).

Based on these results, we assumed that the long reaction time was leading to
product decomposition. To increase the yield, fast quenching was introduced into the work-up
process. The ring-opening reactions were conducted with 63, 64, and 65 again using LiOH.
As a result, the yield of compound 67 increased to 94%; compounds 68 and 69 were also
synthesized in 74% and 51% yields, respectively (Entries 9-11).
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Table 2. Conditions investigated for basic hydrolysis of β-lactams 63-65.

*

Entry

Substrate (R)

Base

Time

Product: yield

1

63 (Bn)

NaOH

30 min

67: 20%

2

63 (Bn)

LiOH

30 min

67: 25%

3

63 (Bn)

KOH

30 min

67: 13%

4

64 (Dpm)

NaOH

30 min

68: 22%

5

64 (Dpm)

LiOH

30 min

68: 29%

6

64 (Dpm)

KOH

30 min

68: trace

7

64 (Dpm)

NaOH

2h

/*

8

64 (Dpm)

LiOH

5 min

68: 67%

9

63 (Bn)

LiOH

5 min

67: 94%

10

64 (Dpm)

LiOH

5 min

68: 74%

11

65 (PMB)

LiOH

5 min

69: 51%

Diphenylmethyl ester decomposition observed; almost no desired product could be isolated.

To avoid any side reactions, the primary alcohol on the side chain and the secondary
amine on the thiazolidine ring of 67-69 needed to be protected. The protection of the primary
alcohol was conducted on the three starting materials (67-69), and the products (70-72) were
isolated in 56-64% yield. The protection of the secondary amine on the thiazolidine ring
accomplished with a Cbz group followed Scornet’s procedure.63 Those reactions were
conducted with compounds 70 and 71, and products 73 and 74 were obtained in ~50% yield
(Scheme 19). Secondary amine protection was also attempted with compound 72, but the
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reaction failed with only starting material recovered (Scheme 23).

Scheme 23. Failed synthesis of compound 75.

The hydrolysis of methyl ester derivatives 73 and 74 was first attempted using basic
hydrolysis64 or lithium iodide65 reaction. Unfortunately, they were not successful; no
reactions occurred and only starting materials were recovered. The work of Nicolaou et al.,66
which uses trimethyltin hydroxide (Me3SnOH) helped solve this problem. Trimethyltin
hydroxide was allowed to react with compound 73 and 74, and compounds 76 and 77 were
obtained in 70% and 74% yields, respectively (Scheme 19).

The thionation was attemped by using Dyer’s method.67 Compound 76 was allowed
to react with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and sodium sulfide
(Na2S) in DMF. The reaction failed, with a complex mixture collected. This reaction was also
conducted in CH2Cl2, but it showed the same result as the reaction in DMF.

To know more about this thionation, a model reaction was set up with compound 62.
This reaction was conducted with EDC and Na2S in DMF first to form thioacid 81 (Scheme
24). The reaction was monitored by

13

C NMR spectroscopy. A signal at 207 ppm was

detected, which suggests the presence of a thioacid carbon and supports the successful
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synthesis of thioacid 81. To obtain more information about this reaction, it was also
conducted in several other solvents (acetone, chloroform, and acetonitrile). As a result, the
thioacid could be synthesized in acetone and acetonitrile, while only starting material was
recovered in chloroform.

Scheme 24. Thionations of model compound 62.

Based on the results from the model reactions, acetonitrile and acetone were chosen
as the solvents for thionations, which were attempted on compounds 76 and 77.
Unfortunately, the reactions failed, and although all starting material had been consumed, a
complex mixture was obtained in each case, with no desired product detected. One possible
reason is that starting materials 76 and 77 are highly functionalized, with several protecting
groups adding steric bulk.

2.5 Conclusions and Future Work
In this project, there are three major goals: 1) synthesis of a series of
penicillin-derived compounds; 2) synthesis of open-lactam compounds (hydrolysis of
β-lactam/thio-lactam compounds); 3) synthesis of thioacid derivatives which could be used as
potential MBL inhibitors. The first goal has been accomplished with some penicillin
derivatives successfully synthesized. The second goal was also accomplished, and we
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successfully established a mild laboratory method for basic hydrolysis of a β-lactam
compound.

However, the synthesis of thioacid might be problematic with no desired product
synthesized. To synthesize penicillin-derived thioacid compounds, two methods were used in
this project: hydrolysis of a thio-lactam or thionation of a carboxylic acid from a hydrolyzed
-lactam compound. Regarding the first method, the formation of a penicillin-derived
thio-lactam compound may not be easy to achieve with Lawesson’s reagent.

During the course of our second thionation strategy, although the synthesis of
thioacid 80 failed because of the highly functionalized starting materials 76 and 77, we
hypothesize that the thionation may be possible on less functionalized penicillin derivatives,
which has been demonstrated here with the successful synthesis of thioacid 81.
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Chapter 3-Modified Synthesis-Inhibitors of Metallo-β-Lactamases via a "Hydroxyl
Release" Strategy

3.1 Research Project Goal
According to previous research,44 dicarboxylic acids have been shown to inhibit
some MBLs because of their strong binding to zinc ions. There is research reported that
opened β-lactam structures can bind to MBL active sites.51 Based on these results, we
hypothesized that the dicarboxylic acids derived from penicillin could also be the potential
inhibitors of MBLs. With modification to our previous research goals, four new targets are
shown in Figure 20. Since the targets can be synthesized from penicillin derivatives and they
also have similar structures to β-lactam antibiotics, they might show high affinities to MBLs.
In addition, this project could also be a proof of the concept of the "release strategy". With
the help of nucleophiles on their side chains, if the proposed compounds were to cyclize and
release OH group from the synthesized carboxylic acid in the presence of an MBL, then it
demonstrates that the release strategy as an MBL inhibition method (which we originally
proposed with thioacids) works.
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Figure 20. Proposed four possible inhibitors.

3.2 Synthesis of (2R,4S)-2-((R)-carboxy(2-hydroxyacetamido)methyl)-5,5-dimethylthia
zolidine-4-carboxylic acid (83)
With modifications to our previous research, the synthesis of 83 is shown in Scheme
25. Compound 83 was synthesized in two deprotection steps from 68, whose synthesis was
described in Chapter 2. The first step was methyl ester deprotection by using trimethyltin
hydroxide62 to yield product 82; and the next step was Dpm ester hydrolysis by using formic
acid69 or trifluoroacetic acid (TFA)69 to yield product 83.

Scheme 25. Synthesis of compound 83.
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The synthesis of compound 82 was conducted by using trimethyltin hydroxide.
Compared to highly functionalized compound 77, the synthesis of compound 82 occurred in
lower yield (30%). This could be explained by the low solubility of 68 in 1,2-dichloroethane.
Product 82 is also very polar, and some of it might have been lost during the aqueous workup
process. After this methyl ester hydrolysis, an inseparable mixture of two diastereomers 82a
and 82b was obtained in a ratio of 3:2, which was determined by measuring the relative
integrations of the α-protons next to the carboxylic acids (labeled red in Figure 21) in 1H
NMR. It is interesting that epimerization at the α-position of the acid occurred during the
hydrolysis process. According to previous work,66, 70, 71, 72 trimethyltin hydroxide should not
lead to epimerization during methyl ester hydrolysis. The reason for epimerization in this
hydrolysis process is still not clear.

Figure 21. Two diastereomers of compound 82.

The hydrolysis of the Dpm ester of 82 was conducted with formic acid. Compound
83 was successfully synthesized in 54% yield. This final product was also isolated as a
mixture of inseparable diastereomers (83a and 83b, Figure 22), since the mixture of 82a and
82b was used as starting materials. The diastereomeric ratio was determined by measuring
the relative integrations of the methylene hydrogens in the 1H NMR spectra, and was found to
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be 1.05:1.

Figure 22. Two diastereomers of compound 83.

3.3 Synthesis of (2R,4S)-2-((1R,2R)-1-carboxy-2,3-dihydroxypropyl)-5,5-dimethylthiaz
olidine-4-carboxylic acid (87)
The successful synthesis of final product 83 showed that β-lactam hydrolysis and
deprotection of the specific functional groups could be a good method to synthesize inhibitors
to MBLs. With modifications to our previous research, an attempted synthesis of compound
87 was undertaken, as shown in scheme 26.

Scheme 26. Attempted synthesis of compound 87.

48

The attempted synthesis of compound 84 was conducted with LiOH in MeOH, as
previously described. Compound 35 is a penicillin derivative with different functional groups
on the side chain. Following our procedure, the basic hydrolysis of 35 failed, and a complex
mixture was obtained without the desired target 84 detected. We assumed that the secondary
alcohol on the side chain may affect the ring opening reaction. As a result, we decided to
protect the secondary alcohol on the side chain with a TBS group, in this case starting with
-bromo penicillin derivative 34 (Scheme 27).

Scheme 27. Synthesis of ring-opened target 91c.

Followed Fujimoto’s method,73 starting with 34, TBS-protected compound 88 was
synthesized in 65% yield. The product was obtained as a mixture of two diastereomers 88a
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and 88b in a ratio of 86:14, which was determined by measuring the relative integrations of
H5 (labeled red in Figure 23) in the 1H NMR spectra.

Figure 23. Two diastereomers of compound 88.

Basic ring opening of 88 was then attempted following our procedure. This reaction
failed, and a complex mixture was obtained without any of the desired target 89 detected. To
decrease the steric hindrance of the structure, compound 90 was synthesized by using PBu3
(Scheme 27). Compared to previous research, this debromination occurred in a low yield of
43% due to the presence of the bulky OTBS group next to it. After the debromination, three
diastereomers were obtained (four diastereomers are expected, two cis and two trans). The
stereochemistry was determined by measuring the coupling constant (J) between the vicinal
hydrogens on the β-lactam ring (H5 and H6, which are labeled in Figure 24). Compound 90a
and inseparable 90b (from 90c) showed J = 1.8 Hz, which suggests trans diastereomers, and
compound 90c was determined as the only cis diastereomers with J = 4.4 Hz. The ratio
between trans and cis was 64:36, which was determined by measuring relative integrations of
H5 in 1H NMR.
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Figure 24. Diastereomers 90a, 90b and 90c.

The basic ring opening was conducted with LiOH in MeOH as previously described,
ring opening of 90a was conducted first. The reaction failed with only starting material
recovered. When using the mixture of diastereomers of compound 90b, 90c, compared to the
previous results, this basic hydrolysis was not a fast reaction. The reaction was monitored by
TLC, and after 3 hours, some starting material was still present. Upon analysis, it was
interesting to observe that only the cis diastereomer 90c underwent β-lactam ring opening to
form 91c under basic conditions, with the trans diastereomers 90b still present, as detected by
1

H NMR spectroscopy. This might be explained by the steric hindrance, the cis diastereomer

90c would have less hindered β-face, which would be the active site for basic ring opening
(Scheme 28).

Scheme 28. Formation of 91c from cis compound 90c. Reaction occurred at less hindered
β-face.

The isolation and characterization of 91c is problematic because it can’t be isolated
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from remaining starting material 90b. From compound 91c to final product 87, there are only
three steps left, which are shown in Scheme 26: TBS removal from both alcohols by using
n-Bu4NF (TBAF); methyl ester hydrolysis by using trimethyltin hydroxide; and Dpm ester
hydrolysis by using formic acid. These three steps have been done in previous research, and
we were confident that the final product 87 could be synthesized following these procedures.
However, we decided to stop this synthesis at the ring opening step. The main problem is that
so many diastereomers were synthesized which couldn’t be fully isolated.

3.4 Synthesis of (2R,4S)-2-((1S)-1-carboxy-2,4-dihydroxybutyl)-5,5-dimethylthiazolidi
ne-4-carboxylic acid (100)
With modification to our previous research, the synthesis of theoretical target 100 is
shown in Scheme 28. This target was chosen to explore the effect of ring size on inhibitory
activity. Derivative 100 contains an extra carbon atom in the side chain compared to 87,
which would lead to a 6-membered ring upon cyclization during our proposed mechanism of
inhibition (Scheme 7). Starting with dibromo-penicillinate 33, the synthesis of compound 100
is shown in scheme 29.
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Scheme 29. Attempted synthesis of target 100.

Aldehyde 94 was synthesized first as shown in Scheme 29. Starting from
1,3-propanediol (92), TBS-protected alcohol 93 was synthesized by using TBSCl and
triethylamine following Lifchit’s procedure74 in 42% yield. After that, desired aldehyde 94
was synthesized using DMP oxidation. This oxidation occurred in a high yield of 89%, which
led to an acceptable overall yield of 37%.
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Based on our previous research, the addition of the side chain was done using
Grignard reagent. However, in this case the reaction required some optimization (Table 3).
Following Testero’s procedure,49 the reaction was first conducted with 5 equiv. of aldehyde
94; at this time, the yield of product could not be measured since the aldehyde (present in
excess) has the same polarity as the product, making it difficult to isolate product 95 (Table 3,
entry 1). When the amount of aldehyde was decreased to 1.0 and 1.5 equiv., 95 was isolated
in yields of 22% and 34% (Entries 2 and 3). The effect of temperature was also determined.
When the reaction mixture was allowed to warm from -78 oC to room temperature, two
diastereomers 95a and 95b were detected, and are shown in Figure 25. The diastereomeric
ratio was 2:1, which was determined by measuring the relative integrations of H5 in the 1H
NMR spectra. This result showed that this reaction outcome is affected by temperature, with
higher temperatures leading to formation of diastereomers (Entry 4).

Figure 25. Two diastereomers 95a and 95b.

After that, we tried to test the influences of the amount of the aldehyde. The reaction
was attempted with 2.5 or 3.0 equiv. of aldehyde; however, the yield of product didn’t change
from 34% yield (Entries 5 and 6). Finally, we determined the influence of reaction time.
When the time was increased to 5 h, the yield increased to 49% (Entry 8). As a result, the best
conditions for the addition of the side chain via a Grignard reaction is 1.5 equiv. of 94 in the
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presence of 33 and EtMgBr at -78 oC for 5 hours.

Table 3. Grignard reactions attempted between 33 and 94 to give 95.

a

Entry

Equiv. of 94

Time (h)a

Temp (oC)

Yield of 95 (%)

1

5.0

4

-78

/b

2

1.0

4

-78

22

3

1.5

4

-78

34

4

1.5

4

-78 - rt

30c

5

2.5

4

-78

34

6

3.0

4

-78

34

7

1.9

5

-78
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Overall time, which includes 2 reactions: 1) reaction of 33 with EtMgBr for 2 h; 2) addition of 94 and stirring

for a further 2-3 h.
b

Product was detected by 1H NMR

c

The reaction was run for 4 h, and the reaction mixture was then allowed to warm to room temperature and

quenched (NH4Cl); inseparable diastereomers 95a and 95b were isolated.

Compound 96 was synthesized from 95 following our previously used procedure. This
reaction yielded only one isomer as the product in 83% yield. The stereochemistry was
determined by measuring the coupling constant (J) between vicinal hydrogens H5 and H6
(Figure 26) in the 1H NMR spectrum (J = 1.7 Hz). The data match the literature value,49 and
is consistent with the trans isomer of 96.

55

Figure 26. trans-Isomer 96.

Following our previous research, the secondary alcohol on 96 was protected with a
TBS group (Scheme 30). This alcohol protection occurred in a low yield of 29%. The product
was isolated as a mixture of two inseparable diastereomers 101a and 101b in a ratio of 5:2,
determined by measuring relative integrations in the 1H NMR spectrum.

The ring opening on the inseparable mixture 101a and 101b was conducted by basic
methanolysis as previously described (Scheme 30). Compared to previous results, because of
the steric hindrance near the lactam carbonyl of 101, the reaction was much slower, requiring
1 h to go to completion. It is interesting that not only the β-lactam ring was opened under the
basic conditions, but the Dpm ester was also hydrolyzed during the extended reaction time.
It’s not clear why this was obtained as the product, since we would expect the methyl ester to
be obtained under these conditions. The yield of inseparable diastereomers 102a and 102b
was 35%, which is lower than our similar reaction on other substrates, in part due to other
unexpected side reactions occurring over the longer reaction time. The ratio of 102a:102b
was 3:1, which was determined by measuring relative integrations of hydrogens in the 1H
NMR spectrum.
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Scheme 30. Synthesis of compound 102.

In a separate experiment, basic hydrolysis was attempted directly on 96. Unlike for
compound 35, the hydrolysis of 96 is very efficient. It was a fast reaction which was
complete in 5 min, giving only one pure product 97, which was isolated in 76% yield
(Scheme 28).

Based on our previous research, the deprotection of methyl ester 97 was conducted
with trimethyltin hydroxide. However, no reaction occurred, with only starting material being
recovered (Scheme 31). We hypothesized that the bulky TBS group may be hindering the
hydrolysis of the methyl ester, therefore alcohol deprotection might need to be conducted
before methyl ester deprotection.

Scheme 31. Attempted synthesis of 103.
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We achieved the deprotection of 97 by using n-Bu4NF,75 and product 98 was
synthesized in 74% yield (Scheme 28). Methyl ester 98 was then deprotected by using
trimethyltin hydroxide, and this time, the reaction was a success, with compound 99 isolated
in 19%. Compared to our previous work, we assumed that the theoretical product should be
carboxylic acid 104 (Figure 27). However, our observations during the reaction and the
HRMS data provided evidence that the product was not 103. Firstly, we observed that the
polarity of the synthesized product was lower than that of the starting material 101, as
measured by TLC (103 is expected to be more polar than 101). Secondly, the HRMS data of
the product was: [M+H]+ m/z calcd for C24H28NO5S: 442.1688; found 442.1682, compared to
103, which has ([M+H]+ m/z calcd for C24H30NO6S: 460.1794. The molecular formula of the
product is consistent with loss of H2O from 101. Based on these observations, we propose
that the structure of the product is lactone 99. This is supported by strong similarity between
the 1H NMR data for synthesized compound 99 and reported lactone 105.76 (Table 4)

Figure 27. Theoretical product after methyl ester deprotection.
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Table 4. Comparison between 1H NMR data for synthesized compound 99 and reported
lactone 105.

1

H NMR (400 MHz, CDCl3)

1

H NMR (500 MHz, CDCl3)

Entry

H

99 (synthesized)

105 (reported)

1

3

3.00 (dd, J = 8.0, 4.7 Hz, 1H)

2.54 (dq, J = 7.2, 7.2 Hz, 1H)

2

4

4.01 (td, J = 7.7, 5.3 Hz, 1H)

3.81-3.88 (m, 1H)

3

5a

1.91 (dtd, J = 14.2, 8.0, 3.8 Hz, 1H)

1.91 (dtd, J = 14.3,6.5, 4.1 Hz, 1H)

4

5b

2.15 (m, 1H)

2.22 (dddd, J = 14.5, 7.9, 4.8, 4.8 Hz, 1H)

5

6a 4.24 (ddd, J = 11.7, 8.4, 3.5 Hz, 1H) 4.26 (ddd, J = 11.5, 6.8, 4.6 Hz, 1H)

6

6b 4.42 (ddd, J = 11.5, 6.5, 3.8 Hz, 1H)

4.48 (ddd, J = 11.7, 7.9, 3.9 Hz, 1H)

The last step of the synthesis was diphenylmethyl ester hydrolysis. This reaction was
attempted using formic acid, but unfortunately, no desired product 100 was detected. Similar
to previous outcomes, diphenylmethyl hydrolysis was evident by the detection of
diphenylmethanol in the organic layer, as revealed by 1H NMR. However, since 100 could
not be isolated, further experiments will be needed to obtain and fully-characterize the final
product.

3.5 Synthesis of (2R,4S)-2-((R)-(2-aminoacetamido)(carboxy)methyl)-5,5-dimethylthia
zolidine-4-carboxylic acid (113)
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Amines are also good nucleophiles, therefore we attempted to incorporate an amine
in the side chain of a potential metallo-β-lactamase inhibitor. Based on our previous research,
a synthetic route is proposed for potential MBL inhibitor 113 (Scheme 32). In this case, we
decided to add the side chain by amide bond formation. This would be followed by β-lactam
ring-opening under basic conditions and three deprotection reactions to provide product 113.

Scheme 32. Attempted synthesis of compound 113.
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The first reaction was the synthesis of phthalimide-protected acyl chloride 107,
which was synthesized from carboxylic acid 106 using oxalyl chloride77 in 98% yield
(Scheme 32). Phthalimide was chosen as the protecting group since it is stable under basic
conditions. The addition of the side chain was then conducted by reacting 28 with 107.
Following a previous procedure,62 compound 108 was synthesized in 93% yield.

Compound

109

was

synthesized following a previous

procedure using

bromodiphenylmethane48. Compared to the previous reactions in Chapter 2, this yield was
very low at only 6%, and several products were obtained making it difficult to isolate the
desired product. The undesired outcome may be due to the low solubility of 108 in
chloroform or acetone, which are the solvents usually chosen for carboxylic acid protection
with a Dpm group.

Ring-opened compound 110 was synthesized under our previously used basic
conditions. Compared to previous outcomes, this basic ring opening occurred in a lower yield
(47%), likely due to steric hindrance on the side chain. To synthesize compound 111, the
phthalimide protecting group in 110 could be removed by using either sodium borohydride
(NaBH4),78 hydrazine,79 or methylamine (MeNH2).76 Because of the limited amount of the
starting material available, the reaction was conducted only with methylamine, but
unfortunately, the reaction failed and a complex mixture was obtained without any of the
desired product detected.
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3.6 Conclusions and Future Work
In this project, the formation of carboxylic acids using basic ring opening of
β-lactam rings has been extended with different penicillin derivatives. By using this method,
some ring-opened penicillin derivatives have been successfully synthesized and have carried
through to potential MBL inhibitors. Among the four proposed targets, two diastereomers of
compound 83 were successfully synthesized. To determine its inhibitory properties, inhibition
assays with MBL enzymes will be needed. Lactone 102 was synthesized as the final product
during the attempted synthesis of 104. The final step (diphenylmethyl ester hydrolysis) has
been attempted and shown to be promising with evidence for the formation of
diphenylmethanol; however, no desired product was isolated, and better reaction conditions
or purification are required for compound 104 synthesis.

During the synthesis of 87, the isolation of the final product was problematic due to
the formation of inseparable diastereomers. Because of the limited time, target compounds 87
and 113 haven’t been synthesized. However, the successful synthesis of methyl esters 91 and
110 have further expanded the substrate scope for the basic ring opening of β-lactam rings.

The synthesis of compound 109 occurred in very low yield. As future work, an
alternative method to synthesize penicillin derivatives with a free amine on the side chain as
the nucleophile is proposed in Scheme 33. This idea originated from the proposed synthesis
of 100. The addition of side chain could be conducted using Grignard reaction of 33 and
aldehyde 114, followed by debromination using PBu3, basic ring opening using LiOH,
compound 116 could be synthesized in two steps. The synthesis of 117 from 116 is also
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proposed according to the synthesis of compound 113. If this alternative theoretical product
117 could be successfully synthesized, its inhibitory activity could also be assayed against
MBL enzymes.

Scheme 33. Proposed synthesis of theoretical compound 117.
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CHAPTER IV-EXPERIMENTAL
GENERAL EXPERIMENTAL SECTION

Solvents
Anhydrous solvents, diethyl ether, dichloromethane, and tetrahydrofuran, were obtained from
an innovative Technology, Inc. Solvent Delivery System before use and stored over 4 Å
molecular sieves. Other solvents, hexanes, ethyl acetate, methanol were purchased as ACS
grade from Pharmco (Brookfield, CT), VWR (Bridgeport, NJ ), MilliporeSigma Chemical
Company (St. Louis, MO), and Alfa Aesar (Haverhill, MA), and used without further
purifications unless otherwise stated.

Reagents
All reagents were purchased from Acros Organics Ltd. (NJ), Alfa-Aesar Chemicals.
(Haverhill, MA), AK Scientific Inc. (Union City, CA), Thermo Fisher Scientific (Waltham,
MA), MilliporeSigma Chemical Company (St. Louis, MO), Oakwood Products, Inc. (Estill,
SC), or Arctom Chemicals (Cambridge, MA). They were all American Chemical Society
(ACS) grade and used without further purification unless otherwise stated.

Reactions
Reaction glassware and magnetic stir bars were stored in an oven at 200 ˚C prior to use.
Sigma-Aldrich Natural Rubber Septa and Teflon coated magnetic stir bars were utilized,
unless otherwise noted. All processes involving air or moisture sensitive reactants and/or
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requiring anhydrous conditions were performed under a positive pressure of nitrogen, unless
otherwise noted. Henke Sass Wolf Norm-Ject® plastic syringes, Air-Tite® sterile hypodermic
needles, and oven-dried 25-cm needles were used for volumetric addition of reagents, unless
otherwise noted. The filtration was done by using glass funnel, and Whatman® qualitative
filter papers, unless otherwise noted.

Chromatography
Preparative thin layer chromatography was accomplished through the use of Sorbtech® Silica
Gel HL with UV 254 glass-backed plates. Flash column chromatography was performed with
SilicaFlash® Irregular Silica Gel, F60 with 40-63 μm particle size. Mobile phases were
freshly prepared as described in the detailed experimental section. Thin layer chromatography
(TLC) analysis was conducted on Sorbtech® Silica Gel HL with UV 254 glass-backed plates
with fluorescent indicator (UV 254). Development of the TLC plate was accomplished by
staining the plate with potassium permanganate stain, unless specific noted. TLC solvent
systems were identical to the mobile phase used for column chromatography, unless
otherwise noted.

Spectroscopy
Nuclear Magnetic Resonance (NMR) spectroscopy was achieved using a Varian Mercury
spectrometer operating at 500 or 400 MHz for 1H and at 126 or 100 MHz for

13

C

spectroscopy. All carbon spectra were proton-decoupled. All 1H resonances were reported
downfield relative to TMS (δ 0 ppm) reference unless otherwise noted. All
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13

C resonances

were referenced to CDCl3 (δ 77 ppm) unless otherwise noted. The following abbreviations
were used to denote the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, p =
pentet, dd = doublet of doublets, dt = doublet of triplets, ABq = AB quartet, br = broad.
Additional assignments were made using pulsed field gradient versions of shift correlation
spectroscopy

(gCOSY),

heteronuclear

single

quantum

coherence

(gHSQC),

and

heteronuclear multiple bond correlation spectroscopy (gHMBC).

Mass spectra (MS) were performed at the University of Illinois and recorded on a high
resolution mass spectrometer (HRMS), using a Waters Q-TOF Ultima ESI, and/or Waters
Synapt G2-Si ESI.

DETAILED EXPERIMENTAL SECTION

(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic
acid (29)

This compound was prepared according to the procedure by Zhang et al.54 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was cooled to -10 to -5 ˚C and charged with hydrobromic acid
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(5 mL, 35%) followed by dropwise addition of liquid bromine (2.50 g, 16.0 mmol) over 2
min. Immediately thereafter, sodium nitrite (0.50 g, 7.2 mmol) was added slowly in one
portion at -10 to -5 ˚C. The reaction mixture was allowed to stir at -10 to -5 ˚C for 10 min,
black colored solution A was obtained and was maintained at -15 to -10 ˚ C for 20 min. An
oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was charged with water (5 mL), and hydrobromic acid
(1.05 mL, 35%) was added quickly in one portion at -15 to -10 ˚C. Immediately thereafter,
6-aminopenicillanic acid (1.08 g, 5.0 mmol) was added in one portion to obtain solution B,
which was cooled to -15 to -10 ˚C. Solution A was added to solution B dropwise over 20 min.
The reaction mixture was warmed to room temperature and stirred for another 2 h. The
precipitate was collected by vacuum filtration, and then washed with a solution of sodium
bisulfite (3 mL, 20%). The product was dried under low pressure for 3 h to yield a white solid
28 (1.03 g, 58% yield). 1H NMR (400 MHz, CDCl3): δ 5.78(s, 1H, CH), 4.57(s, 1H, CH),
1.65 (s, 3H, CH3), 1.56 (s, 3H, CH3).

Benzhydryl (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane2-carboxylate (30)

This compound was prepared with modification to the procedure by Xu et al.56 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was charged with 28 (1.20 g, 3.3 mmol) and dichloromethane
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(5

mL)

and

cooled

to

0

˚C.

Diphenylmethanol

(0.61

g,

3.3

mmol)

and

dicyclohexylcarbodiimide (0.68 g, 3.0 mmol) were added in one portion. Then the reaction
mixture

was

stirred

for

30

min

to

yield

a

light-yellow

colored

solution.

4-Dimethylaminopyridine (0.02 g, 0.17 mmol) was added in one portion, and the color turned
black immediately. The reaction was warmed to room temperature and stirred for another 3 h.
The white precipitate was removed by vacuum filtration, and the filtrate was concentrated
under reduced pressure. The crude dark oil was purified by flash column chromatography
(hexane:ethyl acetate = 3:1) to yield a yellow solid 29 (1.03 g, 59% yield). 1H NMR (400
MHz, CDCl3): δ 7.36(m, 10H, ArH), 6.93 (s, 1H, CO2CHPh2), 5.83 (s, 1H, CH), 4.63 (s, 1H,
CH), 1.61 (s, 3H, CH3), 1.26 (s, 3H, CH3).

2-(tert-Butyldimethylsilyloxy)acetaldehyde (31)

This compound was prepared according to the procedure by Lölsberg et al.57 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with oxalyl
chloride (0.4 mL, 4.1 mmol) and dichloromethane (9 mL), and was cooled to -65 ˚C. A
solution of DMSO (0.7 ml, 9.8 mmol) in dichloromethane (2 mL) was added dropwise to the
reaction mixture over 12 min. The reaction mixture was stirred at -65 ˚C for 10 min. A
solution of alcohol 31 (0.72 g, 4.1 mmol) and pyridine (0.7 mL, 0.8 mmol) in
dichloromethane (3.8 mL) was added to the reaction solution dropwise over 12 min. The
reaction mixture was stirred at -65 ˚C for another 15 min. Triethylamine (2.9 mL, 20.5 mmol,)
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was added dropwise over 8 min. Then the reaction mixture was warmed to 10 ˚C in 5 min
and stirred at this temperature for another 20 min. The reaction mixture was then acidified
with hydrochloric acid (1.0 M) to pH = 4. The reaction mixture was washed with a solution
of concentrated copper (II) sulfate (50 mL) and brine (5 mL). The aqueous layer was
extracted with dichloromethane (3 x 10 mL), and the combined organic layers were dried
with magnesium sulfate, filtered, and concentrated under reduced pressure to yield an
orange-colored oil (0.63 g, 89% yield). 1H NMR (400 MHz, CDCl3): δ 9.70 (t, J = 0.9 Hz, 1H,
CHO), 4.21 (d, J = 0.9 Hz, 2H, CH2), 0.93 (s, 9H, C(CH3)3), 0.10 (s, 6H, Si(CH3)2).

Method B:
This compound was prepared with modification to the procedure by Chen et al.58 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
alcohol 31 (1.00g, 5.7 mmol) and dichloromethane (10 mL). The solution was cooled to 0 ˚C.
Dess-Martin periodinane (1.27g, 6.3 mmol) was added quickly in one portion. The reaction
mixture was stirred for 4 h while slowly warming to room temperature. The reaction mixture
was filtered through a pad of Celite®. The filtrate was concentrated under reduced pressure.
The crude clear liquid was purified by flash column chromatography (hexane:ethyl acetate =
20:1 to 15:1 to 10:1) to yield a clear oil (0.64g, 64% yield). 1H NMR (400 MHz, CDCl3): δ
9.70 (t, J = 0.9 Hz, 1H, CHO), 4.21 (d, J = 0.9 Hz, 2H, CH2), 0.93 (s, 9H, C(CH3)3), 0.10 (s,
6H, Si(CH3)2).
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Benzhydryl (2S,5R)-6-bromo-6-(2-((tert-butyldimethylsilyl)oxy)-1-hydroxyethyl)-3,3-di
methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (32)

This compound was prepared with modification to the procedure by Testero et al.53 An
oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 33
(0.96 g, 1.8 mmol) and anhydrous tetrahydrofuran (35 mL) and cooled to -78 ˚C. The
ethylmagnesium bromide (0.6 mL, 1.8 mmol, 3M in THF) was added dropwise to the
reaction mixture, and the reaction mixture was stirred for 2 h at the same temperature.
Anhydrous aldehyde 32 (1.00 g, 5.7 mmol,) was added dropwise by syringe over 1 min at the
same temperature. The reaction was allowed to stir at -78 ˚C for 2 h. The reaction was
quenched with a saturated aqueous solution of ammonium chloride (10 mL) at -78 ˚C, and
concentrated under reduced pressure. The residue was diluted with water (5 mL) and ethyl
acetate (15 mL). The aqueous layer was extracted with ethyl acetate (3 x 15 mL). The
combined organic layers were washed with a solution of sodium bicarbonate (10 mL, 5%)
and brine (10 mL). The organic layer was dried with magnesium sulfate, filtered, and
concentrated under reduced pressure. The crude residue was purified by flash column
chromatography (hexane:ethyl acetate = 20:1 to 15:1 to 10:1 to 5:1) to give the mixture of
two diastereomers to yield a light-yellow colored oil (770 mg, 69% yield). 1H NMR (400
MHz, CDCl3): δ 7.35 (m, 10H, ArH), 6.93 (s, 1H, CHPh2), 5.76 (s, 1H, CH), 4.60 (s, 1H, CH),
4.11 (t, J = 7.12, 1H, CHOH), 3.91 (m, 2H, CH2), 3.02 (br, 1H, OH), 1.64 (s, 3H, CH3), 1.24
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(s, 3H, CH3), 0.89 (s, 9H, C(CH3)3), 0.09 (s, 6H, Si(CH3)2). 13C NMR (100 MHz, CDCl3): δ
168.38, 168.12, 166.31, 166.29, 139.21, 139.20, 139.14, 139.00, 128.57, 128.56, 128.31,
128.28, 128.23, 128.18, 127.39, 127.37, 127.14, 127.08, 78.32, 78.27, 73.61, 73.22, 72.99,
72.18, 71.64, 71.24, 70.02, 70.00, 64.53, 64.46, 63.83, 63.66, 33.24, 33.17, 25.93, 25.82,
18.21, 18.19, -5.43, -5.47, -5.49. HRMS (ESI) m/z: [M+H]+ Calcd for C29H39NO5SSiBr:
620.1502; found 620.1503.

Benzhydryl (2S,5R)-6-(2-((tert-butyldimethylsilyl)oxy)-1-hydroxyethyl)-3,3-dimethyl-7oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (33)

This compound was prepared with modification to the procedure by Testero et al.53 An
oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 34 (160 mg, 0.3 mmol) and methanol (4 mL) and cooled to 0 ˚C. The
tri-n-butylphosphine (0.1 ml, 0.45 mmol, 97%) was added dropwise by syringe in 1 min. The
reaction mixture was allowed to stir for 1 h at the same temperature. The reaction mixture
was then concentrated under reduced pressure, and the residual was purified by flash column
chromatography (hexane:ethyl acetate = 10:1 to 5:1) to yield a light-yellow colored oil (126
mg, 80% yield). Major:

1

H NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.92 (s, 1H,

CHPh2), 5.38 (d, J = 1.7 Hz, 1H, CHS), 4.56 (s, 1H, NCH), 3.73 (m, 1H, CHOH), 3.41 (dd, J
= 1.7, 7.1 Hz, 1H, CHCHS), 2.67 (d, J = 8.6 Hz, 1H, OH), 1.61 (s, 3H, CH3), 1.24 (s, 3H,
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CH3), 0.90(s, 9H, C(CH3)3), 0.09 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3). Minor: 1H NMR (400
MHz, CDCl3): δ7.34 (m, 10H, ArH), 6.92 (s, 1H, CHPh2), 5.36 (d, J = 1.8 Hz, 1H, CHS),
4.59 (s, 1H, NCH), 4.06 (m, 1H, CHOH), 3.73 (m, 2H, CH2), 3.45 (dd, J = 1.8, 4.9 Hz, 1H,
CHCHS), 2.58 (br, 1H, OH), 1.61 (s, 3H, CH3), 1.24 (s, 3H, CH3), 0.90 (s, 9H, C(CH3)3) ,
0.08 (s, 6H, Si(CH3)2).

13

C NMR (100 MHz, CDCl3): δ 171.94, 171.75, 166.83, 166.75,

169.32, 139.29, 139.24, 139.19, 128.57, 128.55, 128.54, 128.52, 128.28, 128.11, 127.49,
127.45, 127.07, 127.03, 78.16, 78.12, 69.84, 69.75, 69.23, 69.13, 65.39, 65.27, 65.09, 64.87,
64.05, 63.97, 63.92, 33.35, 32.89, 26.01, 25.92, 25.90, 25.84, 18.25, 18.24, -5.41, -5.43.
HRMS (ESI) m/z: [M+H]+ Calcd for C29H40NO5SSi: 542.2396; found 542.2412.

2-(tert-Butyldimethylsilanyloxy)ethanol (39)

This compound was prepared according to the procedure by Cornil et al.68 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
ethylene glycol (6 mL, 107.0 mmol) and pyridine (6 mL). tert-Butyldimethylsilyl chloride
(1.75g, 11.6 mmol) was added quickly in one portion at room temperature. The mixture was
stirred for 2 h. The reaction mixture was quenched with a solution of saturated sodium
bicarbonate (5 mL). The aqueous layer was extracted with diethyl ether (2 x 5 mL). The
combined organic layers were washed with a solution of concentrated copper sulfate (50 mL),
dried with sodium sulfate, filtered, and concentrated under reduced pressure. The crude clear
oil was purified by flash column chromatography (hexane:EtOAc = 95:5 to 90:10) to afford
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colorless oil 31 (2.24 g, 65% yield). 1H NMR (400 MHz, CDCl3): δ 3.70(m, 2, HOCH2), 3.64
(m, 2H, TBSOCH2), 2.07 (m, 1H, OH), 0.91 (s, 9H, C(CH3)3), 0.08 (s, 6H, Si(CH3)2).

2-Pyrrolidinethione (42)

This compound was prepared according to the procedure by Koduri et al.80 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
2-pyrrolidone 41 (100 mg, 1.2 mmol) and dichloromethane (5 ml). Lawesson’s reagent (232
mg, 0.6 mmol) was added in one portion. The reaction mixture was allowed to stir at room
temperature for 2 h. The reaction mixture was concentrated under reduced pressure. The
crude product was purified by flash column chromatography (hexane:ethyl acetate = 4:1 to
3:2) to yield 2-Pyrrolidinethione 42 (90 mg, 0.9 mmol, 75% yield). 1H NMR (400 MHz,
CDCl3): δ 9.04 (br, 1H, NH), 3.58 (m, 2H, CH2NH), 2.82 (m, 2H, CH2CS), 2.10 (m, 2H,
CH2).

(2R,3R)-3-((R)-1-((tert-Butyldimethylsilyl)oxy)ethyl)-4-thioxoazetidin-2-yl acetate (44)

This compound was prepared with modifications to the procedure by Jing et al.81 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
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2-Azetidinone 43 (52 mg, 0.2 mmol) and anhydrous tetrahydrofuran (6 ml). Lawesson’s
reagent (36 mg, 0.1 mmol) was added in one portion. The reaction mixture was stirred at 60
˚C for 6 h. The reaction mixture was concentrated under reduced pressure to yield a yellow
solid. The crude product was purified by flash column chromatography (hexane:ethyl acetate
= 5:1) to yield 2-Azetidininethione (27 mg, 50% yield). 1H NMR (400 MHz, CDCl3): δ 8.10
(br, 1H, NH), 6.15 (br, 1H, CHNH), 4.25 (m, 1H, TBSOCH), 3.07 (m, 1H, CH), 2.11 (s, 3H,
CH3), 1.25 (d, 3H, CH3), 0.86 (s, 9H, C(CH3)3) , 0.08 (s, 6H, Si(CH3)2).

(2S,5R,6R)-6-((tert-butoxycarbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]
heptane-2-carboxylic acid (45)

This compound was prepared according to the procedure by Yang et al.81 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was charged with 6-APA 28 (1.00 g, 4.6 mmol), water (15 mL)
and dioxane (15 ml) at room temperature. Triethylamine (1.3 ml, 9.2 mmol) was added
dropwise by pipette in 1 min. The di-tert-butyldicarbonate (1.31 g, 6.0 mmol) was then added
in one portion. The reaction was allowed to stir at room temperature for 24 h. The reaction
mixture was then concentrated under reduced pressure. The remaining residue was extracted
by dichloromethane (3 x 50 mL) and the combined organic layers were dried with sodium
sulfate, filtered, and concentrated under reduced pressure. The product was dried under
vacuum to yield a white solid. (1.31g, 90% yield). 1H NMR (400 MHz, CDCl3): δ 5.57 (d, J
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= 4.1 Hz, 1H, SCH), 5.34 (m, 1H, NHCH), 5.30 (br, 1H, NH), 4.31 (s, 1H, NCH), 1.66 (s, 3H,
CH3), 1.60 (s, 3H, CH3), 1.44 (s, 9H, C(CH3)3).

Benzyl (2S,5R,6R)-6-((tert-butoxycarbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyc
lo[3.2.0]heptane-2-carboxylate (46)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 45
(365 mg, 1.15 mmol) and anhydrous dimethylformamide (3.2 mL) and was cooled to 0 ˚C.
Triethylamine (0.4 mL, 288 mg, 2.5 mmol) and benzyl bromide (0.3 mL, 428 mg, 2.5 mmol)
were successively added dropwise in 1 min. The reaction mixture was allowed to stir at 45 ˚C
for 4 h. The reaction mixture was then quenched with water (2 mL) and extracted with ethyl
acetate (5 x 25 mL). The combined organic layers were washed with 1N hydrochloric acid (2
x 10 mL), 0.5 N sodium hydroxide solution (2 x 10 mL), and brine (10 mL). The organic
layer was dried with sodium sulfate, filtered, and concentrated under reduced pressure to give
a brown oil. The crude product was purified by flash column chromatography (hexane:ethyl
acetate = 3:1) to yield the product (200 mg, 55% yield). 1H NMR (400 MHz, CDCl3): δ 7.37
(s, 5H, ArH), 5.52 (d, J = 4.2 Hz, 1H, SCN), 5.47 (m, 1H, NHCH), 5.19 (s, 2H, CH2Ph), 4.45
(s, 1H, NCH), 1.55 (s, 3H, CH3), 1.45 (s, 9H, C(CH3)3), 1.42 (s, 3H, CH3).
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Bromodiphenylmethane (47)

This compound was prepared according to the procedure by Gilbert et al.82 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
diphenylmethanol (0.36 g, 1.6 mmol) and dichloromethane (30 mL) and cooled to 0 ˚C. The
phosphorus tribromide (1 mL, 10.5 mmol) was added dropwise in 1 min. The reaction
mixture was warmed to room temperature and allowed to stir for 16 h with a drying tube
containing calcium chloride attached. The reaction mixture was then quenched with water (10
mL). The aqueous layer was extracted with dichloromethane (3 x 20 mL). The combined
organic layers were washed with water (3 x 40 mL) and a solution of saturated sodium
bicarbonate (3 x 40 mL), and dried with magnesium sulfate, filtered, and concentrated under
reduced pressure to give a clear oil. The crude product was crystallized at -20 ˚C for 16 h to
yield a white solid. (0.40 g, 95% yield). 1H NMR (400 MHz, CDCl3): δ 7.30 (m, 10H, ArH),
6.30 (s, 1H, CH).

Benzhydryl (2S,5R,6R)-6-((tert-butoxycarbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-aza
bicyclo[3.2.0]heptane-2-carboxylate (48)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
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100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 45
(730 mg, 2.3 mmol) and anhydrous chloroform (16.8 mL) and was cooled to 0 ˚C.
Triethylamine (0.5 mL, 3.5 mmol) was added dropwise by syringe in 1 min. Then a solution
of tetra-n-butylammonium iodide (460 mg, 1.25 mmol) and bromodiphenylmethane 47 (950
mg, 3.7 mmol) in chloroform (3.4 mL) was added dropwise by syringe in 3 min at the same
temperature. The reaction mixture was allowed to stir at reflux for 6 h. The reaction mixture
was then cooled to room temperature and diluted with ethyl acetate (100 mL). The organic
layer was washed with 1N hydrochloric acid (2 x 5 mL), a solution of sodium bicarbonate (2
x 5 mL, 5%) and brine (5 mL), and dried over sodium sulfate, filtered, and concentrated
under reduced pressure to yield a brown oil. The crude product was purified by flash column
chromatography (hexane:acetone = 3:1) to yield the product (650 mg, 59% yield). 1H NMR
(400 MHz, CDCl3): δ 7.33 (m, 11H, ArH, NH), 6.94 (s, 1H, NH), 5.54 (d, J = 4.9 Hz, 1H,
SCH), 5.47 (m, 1H, NHCH), 4.51 (s, 1H, NCH), 1.62 (s, 3H, CH3), 1.46 (s, 3H, CH3), 1.45 (s,
9H, C(CH3)3).

Benzyl (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-car
boxylate (51)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
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nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 6-APA
28 (1.00 g, 4.6 mmol) and dimethylformamide (8 mL), and was cooled to 0 ˚C. Triethylamine
(1.3 mL, 0.94 g, 9.2 mmol) and benzyl bromide (1.1 mL, 1.58 g, 9.2 mmol) were
successively added dropwise by syringe in 2 min. The reaction mixture was allowed to stir at
45 ˚C for 4 h. The reaction mixture was then diluted with ethyl acetate (10 mL), and the white
precipitate was filtered by gravity filtration. The remaining organic layer was washed with
water (3 x 10 mL), dried with sodium sulfate and concentrated to a half of its original volume,
and was cooled to 0 ˚C. After that, a solution of p-toluenesulfonic acid (880 mg) in ethyl
acetate (15 mL) was added to yield the ammonium salt of the benzylated 6-APA as a white
solid. The white solid was dissolved in ethyl acetate (50 mL), and washed with a solution of
saturated sodium bicarbonate (50 mL), water (50 mL), and brine (50 mL). The organic layer
was dried with magnesium sulfate, filtered, and concentrated under reduced pressure to yield
a white solid 51 (285 mg, 20% yield). 1H NMR (400 MHz, CDCl3): δ 7.38 (m, 5H, ArH),
6.18 (s, 1H, CH), 5.19 (d, J = 1.5 Hz, 2H, CH2Ph), 4.42 (s, 1H, NCH), 1.63 (s, 3H, CH3),
1.38 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ 167.94, 166.33, 134.89, 128.66, 128.63,
128.59, 70.07, 68.94, 67.29, 64.14, 63.00, 33.96, 25.82.

(2S)-2-((Benzyloxy)carbonyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-6-di
azonium (52)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
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100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
benzylated 6-APA 51 (384 mg, 1.3 mmol) and dichloromethane (35 mL), and was cooled to 0
˚C. Sodium nitrite (1.42g, 20.6 mmol) and p-toluenesulfonic acid (284 mg, 1.7 mmol) was
added in one portion. The reaction mixture was allowed to stir at 0 ˚C for 10 min. The
reaction mixture was then washed with brine (10 mL) and dried with sodium sulfate, filtered,
and concentrated under reduced pressure to yield a dark-yellow oil (222 mg, 55% yield). 1H
NMR (400 MHz, CDCl3): δ 7.38 (m, 5H, ArH), 6.18 (s, 1H, N2CH), 5.31 (s, 1H, SCH), 5.19
(d, J = 1.6 Hz, 2H, CH2Ph), 4.41 (s, 1H, NCH), 1.63 (s, 3H, CH3), 1.38 (s, 3H, CH3).

Benzyl (2S,6S)-6-methoxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carb
oxylate (53)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 52
(222 mg, 0.6 mmol) and methanol (5 mL). The reaction was allowed to stir at room
temperature for 16 h. The reaction mixture was then concentrated under reduced pressure.
The residue was purified by flash column chromatography (hexane:ethyl acetate = 5:1) to
yield product (62 mg, 32% yield). 1H NMR (400 MHz, CDCl3): δ 7.37 (m, 5H, ArH), 5.30 (d,
J = 1.4 Hz, 1H, SCH), 5.18 (d, J = 1.8 Hz, 2H, CH2Ph), 4.57 (d, J = 1.4, 1H, CH3OCH), 4.51
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(s, 1H, NCH), 3.52 (s, 3H, OCH3), 1.53 (s, 3H, CH3), 1.38 (s, 3H, CH3).

Benzyl (2S,6R)-6-methoxy-3,3-dimethyl-7-thioxo-4-thia-1-azabicyclo[3.2.0]heptane-2-ca
rboxylate (54)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with Benzyl
6-methoxypenicillanate 53 (91 mg, 0.28 mmol) and anhydrous toluene (4.5 mL). Lawesson’s
reagent (113 mg, 0.28 mmol) was added in one portion. The reaction mixture was allowed to
stir at room temperature for 15 min and then heated to 85 ˚C and stirred for another 1 h. The
reaction mixture was then concentrated under reduced pressure. The crude product was
filtered over silica gel with dichloromethane (50 mL). The filtrate was concentrated under
reduced pressure. The crude product was purified by prep TLC (hexane:ethyl acetate = 8:1) to
yield product (15 mg, 16% yield). 1H NMR (400 MHz, CDCl3) δ 7.38 (m, 5H, ArH), 5.68 (d,
J = 1 Hz, 1H, SCH), 5.21 (s, 2H, CH2Ph), 4.81 (s, 1H, NCH), 4.28 (d, J = 1 Hz, 1H,
CH3OCH), 3.60(s, 3H, OCH3), 1.61 (s, 3H, CH3), 1.41 (s, 3H, CH3).

tert-Butyl (2-hydroxyethyl)carbamate (55)

This compound was prepared with modification to the procedure by Devine et al.83 An
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oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
aminoethanol (0.62 g, 0.6 mL) and anhydrous dichloromethane (20 mL). Triethylamine (1.9
mL, 13 mmol) was added dropwise in 2 min. The reaction mixture was allowed to stir at
room temperature for 30 min, and was cooled to 0 ˚C. A solution of di-tert-butylcarbonate
(2.00 g, 9 mmol) in dichloromethane (6 mL) was added dropwise in 6 min. The reaction
mixture was then warmed to room temperature and allowed to stir at room temperature for 16
h. The reaction mixture was quenched with a solution of saturated ammonium chloride (10
mL), and extracted with dichloromethane (3 x 20 mL). The combined organic layers were
dried with sodium sulfate, filtered, and concentrated under reduced pressure to yield a clear
liquid. The crude product was purified by flash column chromatography (hexane:ethyl acetate
= 3:2) to yield product. (1.50 g, 93% yield). 1H NMR (400 MHz, CDCl3): δ 4.92 (br, 1H, NH),
3.70 (q, J = 4.9 Hz, 2H, HOCH2), 3.27 (q, J = 5.3 Hz, 2H, HNCH2), 1.45 (s, 9H, C(CH3)3).

(2S,5R,6R)-6-(2-Acetoxyacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan
e-2-carboxylic acid (62)

This compound was prepared with modification to the procedure by Solovskii et al.62 An
oven-dried 250-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
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6-APA 28 (1.08 g, 5 mmol), phosphate buffer solution (100 mL, 0.1 M, pH 6.6), and a
solution of sodium bicarbonate (20 mL, 10%). The reaction mixture was cooled to 0 ˚C. A
solution of acetoxyacetyl chloride (0.8 mL, 955 mg, 7.5 mmol) in acetone (20 mL) was added
dropwise by addition funnel in 20 min. The reaction mixture was allowed to stir at the same
temperature for 20 min. After reaction completion, the reaction mixture was then extracted
with diethyl ether (2 x 10 mL). The aqueous layer was acidified with 1 N hydrochloric acid to
pH 2.0. The remaining aqueous layer was extracted with ethyl acetate (3 x 20 mL). The
combined organic layers were dried with sodium sulfate, filtered, and concentrated under
reduced pressure to yield an orange solid (1.42 g, 90% yield). 1H NMR (400 MHz, CDCl3): δ
6.83 (d, J = 8.9 Hz, 1H, NH), 5.76 (dd, J = 4.2, 9.1 Hz, 1H, NHCH), 5.58 (d, J = 4.4 Hz, 1H,
SCH), 4.66 (ABq, J = 15.8 Hz, 2H, CH2CO), 4.51 (s, 1H, NCH), 2.21 (s, 3H, CH3), 1.73 (s,
3H, CH3), 1.63 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ 173.03, 171.87, 169.70, 167.74,
70.31, 67.35, 64.51, 62.40, 57.89, 31.24, 26.77, 20.88. HRMS (ESI): [M+H]+ m/z calcd for
C12H17N2O6S: 317.0807; found 317.0807.

Benzyl (2S,5R,6R)-6-(2-acetoxyacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]
heptane-2-carboxylate (63)

This compound was prepared with modification to the procedure by Tarhonskaya et al.84 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
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and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
benzyl 6-aminopenicillanate 51 (572 mg, 1.8 mmol) and dichloromethane (8 mL), and was
cooled to 0 ˚C. Triethylamine (0.22 g, 0.3 mL, 2.2 mmol) was added dropwise in 1 min.
Acetoxyacetyl chloride (369 mg, 0.3 mL) was added dropwise at the same temperature. The
reaction mixture was warmed to room temperature and allowed to stir for 6 h. The reaction
mixture was then washed with brine (5 mL), and the organic layer was dried with sodium
sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by
flash column chromatography (hexane:ethyl acetate = 3:1) to yield a yellow oil (609 mg, 1.5
mmol, 83% yield). 1H NMR (400 MHz, CDCl3): δ 7.37 (m, 5H, ArH), 6.85 (d, J = 9.2 Hz, 1H,
NH), 5.70 (dd, J = 9.2, 4.2 Hz, 1H, NHCH), 5.57 (d, J = 4.3 Hz, 1H, SCH), 5.19 (d, J = 1.3
Hz, 2H, CH2Ph), 4.62 (ABq, J = 15.8 Hz, 2H, CH2CO), 4.49 (s, 1H, NCH), 2.18 (s, 3H, CH3),
1.63 (s, 3H, CH3), 1.43 (s, 3H, CH3). HRMS (ESI): [M+Na]+ m/z calcd for C19H22N2O6SNa:
429.1096; found 429.1086.

Method B:

This compound was prepared with modification to the procedure by Palena et al.52 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
acetyl protected 6-APA 62 (316 mg, 1 mmol) and acetone (8.0 mL), and was cooled to 0 ˚C.
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Triethylamine (0.2 mL, 121 mg, 1.2 mmol) and benzyl bromide (0.1 mL, 205 mg, 1.2 mmol)
were added dropwise. The reaction mixture was allowed to stir at 45 ˚C for 4 h. The white
precipitate was removed by gravity filtration. The organic layer was then concentrated under
reduced pressure. The remaining residue was diluted with ethyl acetate (20 mL), and washed
with water (3 x 10 mL). The organic layer was then dried with sodium sulfate, filtered, and
concentrated under reduced pressure. The crude product was purified by flash column
chromatography (hexane:ethyl acetate = 3:1) to yield a light yellow solid (162 mg, 40%
yield). 1H NMR (400 MHz, CDCl3): δ 7.37 (m, 5H, ArH), 6.85 (d, J = 9.2 Hz, 1H, NH), 5.70
(dd, J = 9.2, 4.2 Hz, 1H, NHCH), 5.57 (d, J = 4.3 Hz, 1H, SCH), 5.19 (d, J = 1.3 Hz, 2H,
CH2Ph), 4.62 (ABq, J = 15.8 Hz, 2H, CH2CO), 4.49 (s, 1H, NCH), 2.18 (s, 3H, CH3), 1.63 (s,
3H, CH3), 1.43 (s, 3H, CH3).

Benzhydryl (2S,5R,6R)-6-(2-acetoxyacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo
[3.2.0]heptane-2-carboxylate (64)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with the
acetyl protected 6-APA 62 (316 mg, 1 mmol), acetone (8.4 mL), and was cooled to 0 ˚C.
Triethylamine (0.2 mL, 1.2 mmol) was added dropwise in 1 min. Then a solution of
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tetra-n-butylammonium iodide (147 mg, 0.4 mmol) and bromodiphenylmethane (308 mg, 1.2
mmol) in chloroform (1.7 mL) was added dropwise in 2 min. The reaction mixture was
allowed to stir at reflux for 6 h. The reaction mixture was then diluted with ethyl acetate (100
mL) and washed with a solution of 1 N hydrochloric acid (2 x 5 mL), sodium bicarbonate (2
x 5 mL, 5%), and brine (5 mL). The organic layer was dried with sodium sulfate, filtered, and
concentrated under reduced pressure. The crude product was purified by flash column
chromatography (hexane:acetone = 3:1) to yield a light yellow solid (145 mg, 30% yield). 1H
NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.94 (s, 1H, CHPh2), 6.89 (d, J = 9.1 Hz,
1H, NH), 5.71 (dd, J = 4.2, 9.1 Hz, 1H, NHCH), 5.59 (d, J = 4.2 Hz, 1H, SCH), 4.61 (ABq, J
= 24.1 Hz, 2H, CH2CO), 4.56 (s, 1H, NCH), 2.17 (s, 3H, CH3), 1.63 (s, 3H, CH3), 1.28 (s, 3H,
CH3). HRMS (ESI): [M+Na]+ m/z calcd for C25H26N2O6SNa: 505.1409; found 505.1405.

4-Methoxybenzyl (2S,5R,6R)-6-(2-acetoxyacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabi
cyclo[3.2.0]heptane-2-carboxylate (65)

This compound was prepared with modification to the procedure by Scornet et al.63 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
acetyl protected 6-APA 62 (316mg, 1 mmol), acetone (2 mL), and anhydrous chloroform (5
mL), and was cooled to 0 ˚C. Triethylamine (121 mg, 0.17 mL, 1.2 mmol) was added
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dropwise. A solution

of p-methoxybenzyl

chloride (236 mg, 1.5 mmol) and

tetra-n-butylammonium bromide (483 mg, 1.5 mmol) in anhydrous chloroform (3.0 mL) was
added dropwise by syringe in 3 min. The reaction mixture was allowed to stir at room
temperature for 16 h. The reaction mixture was then poured into water (10 mL) slowly. The
mixture was then extracted with ethyl acetate (3 x 10 mL). The combined organic layers were
washed with a solution of saturated sodium bicarbonate (10 mL) and brine (2 x 10 mL). The
organic layer was dried with magnesium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:acetone =
3: 1) to yield a light-yellow solid (100 mg, 23% yield). 1H NMR (400 MHz, CDCl3): δ 7.30
(d, J = 2.5 Hz, 2H, ArH), 6.89 (d, J = 2.5 Hz, 2H, ArH), 6.81 (d, J = 9.4 Hz, 1H, NH), 5.71
(dd, J = 4.3, 9.3 Hz, 1H, NHCH), 5.55 (d, J = 4.3 Hz, 1H, SCH), 5.14 (ABq, J = 19.8 Hz, 2H,
CH2CO), 4.62 (s, 1H, NCH), 3.81 (s, 3H, OCH3), 2.18 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.41
(s, 3H, CH3).

Benzyl (2R,4S)-2-((R)-1-(2-hydroxyacetamido)-2-methoxy-2-oxoethyl)-5,5-dimethylthia
zolidine-4-carboxylate (67)

An oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with Acetyl benzyl 6-aminopenicillanate 63 (203 mg, 0.5 mmol) and methanol (5 mL), and
was cooled to 0 ˚C. Lithium hydroxide (24 mg, 1 mmol) was added to the reaction mixture in
86

one portion. The reaction was allowed to stir at 0 ˚C for 5 min. Immediately thereafter, the
reaction was quenched with a solution of saturated ammonium chloride (5 mL). The
remaining methanol was removed under reduced pressure. The residue was extracted with
ethyl acetate (3 x 10 mL). The combined organic layers were dried with magnesium sulfate,
filtered, and concentrated under reduced pressure to yield a yellow residue. The crude product
was purified by flash column chromatography (hexane:acetone = 3:1) to yield a light-yellow
solid. (186 mg, 94% yield). 1H NMR (400 MHz, CDCl3): δ 7.36 (m, 5H, ArH), 7.19 (d, J =
8.8 Hz, 1H, CONH), 5.18 (ABq, J = 42.4 Hz, 2H, CH2Ph), 5.11 (d, J = 5.5 Hz, 1H, SCH),
4.66 (dd, J = 5.5, 8.8 Hz, 1H, CONHCH), 4.15 (d, J = 5.2 Hz, 2H,HOCH2), 3.78 (s, 1H,
NHCH), 3.76 (s, 3H, OCH3), 3.46 (t, J = 9.6 Hz, 1H, NH), 3.06 (t, J = 5.5 Hz, 1H, OH), 1.53
(s, 3H, CH3), 1.12 (s, 3H, CH3).

13

C NMR (100 MHz, CDCl3): δ 172.31, 170.47, 169.34,

134.81, 128.79, 128.73, 128.68, 72.68, 67.42, 66.22, 62.14, 59.02, 56.76, 52.76, 27.19, 26.66.
HRMS (ESI): [M+H]+ m/z calcd for C18H25N2O6S: 397.1433; found 397.1428.

Benzhydryl (2R,4S)-2-((R)-1-(2-hydroxyacetamido)-2-methoxy-2-oxoethyl)-5,5-dimethy
lthiazolidine-4-carboxylate (68)

An oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with acetyl benzhydryl 6-aminopenicillanate 64 (241 mg, 0.5 mmol) and methanol (5 mL),
and was cooled to 0 ˚C. Lithium hydroxide (24 mg, 1 mmol) was added to the reaction
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mixture in one portion. The reaction was allowed to stir at 0 ˚C for 5 min. Immediately
thereafter, the reaction was quenched with a solution of concentrated ammonium chloride (5
mL). The remaining methanol was removed under reduced pressure. The residue was
extracted with ethyl acetate (3 x 10 mL). The combined organic layers were dried with
magnesium sulfate, filtered, and concentrated under reduced pressure to yield a yellow
residue. The crude product was purified by flash column chromatography (hexane:acetone =
3:1) to yield a light-yellow solid. (175 mg, 74% yield). 1H NMR (400 MHz, CDCl3): δ 7.34
(m, 10H, ArH), 7.16 (d, J = 8.6 Hz, 1H, CONH), 6.94 (s, 1H, CHPH2), 5.11 (d, J = 5.1 Hz,
1H, SCH), 4.66 (dd, J = 5.1, 8.6 Hz, 1H, CONHCH), 4.15 (d, J = 3.9 Hz, 2H, CH2), 3.85 (s,
1H, NHCH), 3.75 (s, 3H, OCH3), 3.46 (br, 1H, NH), 3.06 (t, J = 5.1 Hz, 1H, OH), 1.57(s, 3H,
CH3), 0.98 (s, 3H, CH3). HRMS (ESI): [M+H]+ m/z calcd for C24H29N2O6S: 473.1746; found
473.1746.

4-Methoxybenzyl (2R,4S)-2-((R)-1-(2-hydroxyacetamido)-2-methoxy-2-oxoethyl)-5,5-di
methylthiazolidine-4-carboxylate (69)

An oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with Acetyl PMB 6-aminopenicillanate 65 (100 mg, 0.23 mmol) and methanol (5 mL), and
was cooled to 0 ˚C. Lithium hydroxide (11 mg, 0.46 mmol) was added to the reaction mixture
in one portion. The reaction was allowed to stir at 0 ˚C for 5 min. Immediately thereafter, the
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reaction was quenched with a solution of saturated ammonium chloride (5 mL). The
remaining methanol was removed under reduced pressure. The residue was extracted with
ethyl acetate (3 x 10 mL). The combined organic layers were dried with magnesium sulfate,
filtered, and concentrated under reduced pressure to yield a yellow residue. The crude product
was purified by flash column chromatography (hexane:acetone = 3:1) to yield a light yellow
solid. (50 mg, 51% yield). 1H NMR (400 MHz, CDCl3): δ 7.29 (d, J = 8.8 Hz, 2H, ArH), 7.13
(d, J = 8.8 Hz, 1H, CONH), 6.88 (d, J = 8.7 Hz, 2H, ArH), 5.11 (d, J = 5.0 Hz, 1H, SCH),
5.11 (ABq, J = 51.9 Hz, 2H, COCH2), 4.65 (dd, J = 5.0, 8.7 Hz, 1H, CONHCH), 4.16 (d, J =
3.3 Hz, 2H, CH2PH), 3.81 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.73 (s, 1H, NHCH), 3.44 (br,
1H, NH), 2.89 (br, 1H, OH), 1.51(s, 3H, CH3), 1.10 (s, 3H, CH3).

Benzyl (2R,4S)-5,5-dimethyl-2-((R)-9,9,10,10-tetramethyl-3,6-dioxo-2,8-dioxa-5-aza-9-si
laundecan-4-yl)thiazolidine-4-carboxylate (70)

This compound was prepared with modification to the procedure by Fujimoto et al.73 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 67
(396 mg, 1 mmol) and dichloromethane (10 mL). tert-Butyldimethylsilyl chloride (181 mg,
1.2 mmol) and imidazole (170 mg, 2.5 mmol) were added in one portion. The reaction
mixture was allowed to stir at room temperature for 16 h. The reaction mixture was then
washed with a solution of saturated ammonium chloride (5 mL), and brine (5 mL). The
89

organic layer was dried with magnesium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:ethyl
acetate = 5:1) to yield a light-yellow solid. (326 mg, 64% yield) 1H NMR (400 MHz, CDCl3):
δ 7.40 (d, J = 9.1 Hz, 1H, CONH), 7.34 (m, 5H, ArH), 5.17 (d, J = 4.0 Hz, 1H, SCH), 5.16
(ABq, J = 29.7 Hz, 2H, CH2Ph), 4.63 (dd, J = 4.0, 9.1 Hz, 1H, CONHCH), 4.12 (d, J = 3.3
Hz, 2H, COCH2), 3.77 (s, 1H, NHCH), 3.75 (s, 3H, OCH3), 3.42 (t, J = 9.1 Hz, 1H, NH),
1.51 (s, 3H, CH3), 1.11 (s, 3H, CH3), 0.88 (s, 9H, C(CH3)3), 0.09 (s, 3H, SiCH3), 0.07 (s, 3H,
SiCH3).

13

C NMR (100 MHz, CDCl3): δ 171.19, 170.19, 169.10, 134.85, 128.79, 128.69,

128.65, 73.02, 67.28, 66.54, 63.02, 59.08, 56.61, 52.62, 26.89, 26.59, 25.66, 18.04, -5.58,
-5.64.

Benzhydryl (2R,4S)-5,5-dimethyl-2-((R)-9,9,10,10-tetramethyl-3,6-dioxo-2,8-dioxa-5-az
a-9-silaundecan-4-yl)thiazolidine-4-carboxylate (71)

This compound was prepared according to the procedure by Fujimoto et al.73 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 68
(472 mg, 1 mmol) and dichloromethane (10 mL). tert-Butyldimethylsilyl chloride (181 mg,
1.2 mmol) and imidazole (170 mg, 2.5 mmol) were added in one portion. The reaction
mixture was allowed to stir at room temperature for 16 h. The reaction mixture was then
washed with a solution of saturated ammonium chloride (5 mL), and brine (5 mL). The
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organic layer was dried with sodium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:ethyl
acetate = 5:1) to yield a light yellow solid. (328 mg, 56% yield) 1H NMR (400 MHz, CDCl3):
δ 7.42 (d, J = 9.0 Hz, 1H, CONH), 7.34 (m, 10H, ArH), 6.94 (s, 1H, CHPh2), 5.18 (dd, J =
4.0, 8.4 Hz, 1H, SCH), 4.64 (dd, J = 4.0, 8.9, 1H, CONHCH), 4.15 (ABq, J = 20.3 Hz, 2H,
CH2Ph), 3.84 (d, J = 11.1 Hz, 1H, NHCH), 3.76 (s, 3H, OCH3), 3.42 (t, J = 10.0 Hz, 1H, NH),
1.56 (s, 3H, CH3), 0.98 (s, 3H, CH3), 0.88 (s, 9H, C(CH3)3), 0.10 (s, 3H, SiCH3), 0.09 (s, 3H,
SiCH3).

13

C NMR (100 MHz, CDCl3): δ 171.28, 170.22, 168.59, 139.20, 139.07, 128.61,

128.53, 128.44, 128.10, 127.74, 126.90, 78.32, 73.00, 66.43, 63.05, 59.06, 56.50, 52.64,
26.89, 26.33, 25.68, 18.05, -5.50, -5.60.

4-Methoxybenzyl (2R,4S)-5,5-dimethyl-2-((R)-9,9,10,10-tetramethyl-3,6-dioxo-2,8-dioxa
-5-aza-9-silaundecan-4-yl)thiazolidine-4-carboxylate (72)

This compound was prepared according to the procedure by Fujimoto et al.73 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 69 (50
mg, 0.12 mmol) and dichloromethane (5 mL). tert-Butyldimethylsilyl chloride (21 mg, 0.14
mmol) and imidazole (20 mg, 0.3 mmol) were added in one portion. The reaction mixture
was allowed to stir at room temperature overnight. The reaction mixture was then washed
with a solution of saturated ammonium chloride (5 mL), and brine (5 mL). The organic layer
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was dried with sodium sulfate, filtered, and concentrated under reduced pressure. The crude
product was purified by flash column chromatography (hexane:ethyl acetate = 5:1) to yield
the product. (40 mg, 62% yield) 1H NMR (400 MHz, CDCl3): δ 7.41 (d, J = 9.0 Hz, 1H,
CONH), 7.28 (d, J = 8.7 Hz, 2H, ArH), 6.88 (d, J = 8.7 Hz, 2H, ArH), 5.18 (d, J = 4.0 Hz, 1H,
SCH), 5.08 (ABq, J = 39.9 Hz, 2H, CH2Ph), 4.63 (dd, J = 4.0, 9.0 Hz, 1H, CONHCH), 4.13
(ABq, J = 18.7 Hz, 2H, COCH2), 3.81 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.72 (s, 1H,
NHCH), 3.41 (t, J = 10.2 Hz, 1H, NH), 1.50 (s, 3H, CH3), 1.10 (s, 3H, CH3), 0.89 (s, 9H,
C(CH3)3), 0.10 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3).

Dibenzyl (2R,4S)-5,5-dimethyl-2-((R)-9,9,10,10-tetramethyl-3,6-dioxo-2,8-dioxa-5-aza-9
-silaundecan-4-yl)thiazolidine-3,4-dicarboxylate (73)

This compound was prepared with modification to the procedure by Scornet et al.63 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 70
(128 mg, 0.25 mmol) and anhydrous dichloromethane (5 mL). Diethylpropylethylamine (90
μL, 0.49 mmol) was added dropwise. The reaction mixture was heated to reflux and benzyl
chloroformate was added in 5 portions every 1.5 h (5 x 70 μL, 5 x 0.49 mmol), and was
allowed to stir at the same temperature for 16 h. The reaction mixture was then concentrated
under reduced pressure, and the residue was purified by flash column chromatography
(hexane:ethyl acetate = 3:1) to yield the product (81 mg, 50% yield) 1H NMR (400 MHz,
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CDCl3): δ 7.68 (d, J = 9.2 Hz, 1H, NH), 7.31 (m, 10H, ArH), 5.76 (br, 1H, SCH), 5.30 (br,
1H, NHCH), 4.98 (ABq, J = 18.7 Hz, 2H, CH2Ph),4.89 (s, 2H, COCH2Ph), 4.40 (s, 1H,
NCH), 4.10 (ABq, J = 21.3 Hz, 2H, COCH2), 3.75 (s, 3H, OCH3), 1.58 (s, 3H, CH3), 1.27 (s,
3H, CH3), 0.93 (s, 9H, C(CH3)3), 0.12 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3).

4-Benzhydryl 3-benzyl (2R,4S)-5,5-dimethyl-2-((R)-9,9,10,10-tetramethyl-3,6-dioxo-2,8
-dioxa-5-aza-9-silaundecan-4-yl)thiazolidine-3,4-dicarboxylate (74)

This compound was prepared according to the procedure by Scornet et al.63 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 71
(147 mg, 0.25 mmol) and anhydrous dichloromethane (5 mL). Diethylpropylethylamine (90
μL, 0.49 mmol) was added dropwise. The reaction mixture was heated to reflux and benzyl
chloroformate was added in 5 portions every 1.5 h (5 x 70 μL, 5 x 0.49 mmol), and was
allowed to stir at the same temperature for 16 h. The reaction mixture was then concentrated
under reduced pressure, and the residue was purified by flash column chromatography
(hexane:ethyl acetate = 3:1) to yield the product (87 mg, 49% yield) 1H NMR (400 MHz,
CDCl3): δ 7.69 (d, J = 9.2 Hz, 1H, NH), 7.31 (m, 15H, ArH), 6.84 (s, 1H, CHPh2), 5.82 (d, J
= 5.9 Hz, 1H, SCH), 5.30 (m, 1H, NHCH), 4.96 (m, 2H, CH2Ph), 4.47 (s, 1H, NCH), 4.09
(ABq, J = 25.6 Hz, 2H, COCH2), 3.75 (s, 3H, OCH3), 1.65 (s, 3H, CH3), 1.16 (s, 3H, CH3),
0.93 (s, 9H, C(CH3)3), 0.11 (s, 3H, SiCH3), 0.10 (s, 3H, SiCH3).
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(R)-2-((2R,4S)-3,4-bis((Benzyloxy)carbonyl)-5,5-dimethylthiazolidin-2-yl)-2-(2-((tert-but
yldimethylsilyl)oxy)acetamido)acetic acid (76)

This compound was prepared with modification to the procedure by Nicolaou et al.66 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 73 (81 mg, 0.13 mmol) and 1,2-dichloroethane (5 mL). Trimethyltin hydroxide
(63 mg, 0.39 mmol) was added in one portion. The reaction mixture was heated to 80 ˚C, and
was allowed to stir at the same temperature for 6 h. The mixture was then concentrated under
reduced pressure, and the residue was diluted with ethyl acetate (15 mL). The organic layer
was washed with a solution of saturated ammonium chloride (5 mL), and brine (5 mL). The
organic layer was then dried with magnesium sulfate, filtered, and concentrated under
reduced pressure. The crude product was purified by flash column chromatography
(hexane:acetone = 1:1) to yield a light-yellow oil (57 mg, 70% yield). 1H NMR (400 MHz,
CDCl3): δ 8.06 (d, J = 6.0 Hz, 1H, NH), 7.31 (m, 10H, ArH), 5.79 (d, J = 6.6 Hz, 1H, SCH),
5.21 (t, J = 7.4 Hz, 1H, NHCH), 4.98 (ABq, J = 38.6 Hz, 2H, CH2Ph), 4.87 (s, 2H,
COCH2Ph), 4.41 (s, 1H, NCH), 4.14 (s, 2H, COCH2), 1.64 (s, 3H, CH3), 1.26 (s, 3H, CH3),
0.93 (s, 9H, C(CH3)3), 0.12 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3). 13C NMR (100 MHz, CDCl3):
δ 172.79, 172.37, 169.34, 156.25, 135.19, 134.88, 128.54, 128.51, 128.27, 74.39, 68.33,
67.11, 64.50, 62.96, 57.59, 51.44, 33.23, 25.77, 18.18, -5.56, -5.58.
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(R)-2-((2R,4S)-4-((Benzhydryloxy)carbonyl)-3-((benzyloxy)carbonyl)-5,5-dimethylthiazo
lidin-2-yl)-2-(2-((tert-butyldimethylsilyl)oxy)acetamido)acetic acid (77)

This compound was prepared with modification to the procedure by Nicolaou et al.66 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 74 (87 mg, 0.12 mmol) and 1,2-dichloroethane (5 mL). Trimethyltin hydroxide
(58 mg, 0.36 mmol) was added in one portion. The reaction mixture was heated to 80 ˚C, and
was allowed to stir at the same temperature for 6 h. The mixture was then concentrated under
reduced pressure, and the residue was diluted with ethyl acetate (15 mL). The organic layer
was washed with a solution of saturate ammonium chloride (5 mL), and brine (5 mL). The
organic layer was then dried with sodium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:acetone =
1:1) to yield a light yellow oil (63 mg, 74% yield). 1H NMR (400 MHz, CDCl3): δ 8.15 (br,
1H, NH), 7.29 (m, 15H, ArH), 6.82 (s, 1H, CHPh2), 5.88 (d, J = 6.9 Hz, 1H, SCH), 5.19 (t, J
= 7.6 Hz, 1H, NHCH), 4.96 (d, J = 12.3 Hz, 2H, CH2Ph), 4.47 (s, 1H, NCH), 4.14 (ABq, J =
24.3 Hz, 2H, COCH2), 1.66 (s, 3H, CH3), 1.15 (s, 3H, CH3), 0.92 (s, 9H, C(CH3)3), 0.11 (s,
3H, SiCH3), 0.10 (s, 3H, SiCH3).
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(2R,5R,6R)-6-(2-Acetoxyacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan
e-2-carbothioic S-acid (81)

This compound was prepared with modification to the procedure by Dyer et al.67 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
acetyl protected 6-APA 62 (316mg, 1 mmol), DMF (5 mL), and was cooled to 0 ˚C.
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (186 mg, 1.2 mmol), and sodium sulfide
(234 mg, 3 mmol) were added in one portion. The mixture was warmed to room temperature
and allowed to stir for 4 h. The reaction mixture was washed with brine (3 x 5 mL), extracted
with ethyl acetate (3 x 10 mL). The combined organic layers were dried with sodium sulfate,
filtered, and concentrated under reduced pressure to yield crude product. 1HNMR (400 MHz,
CDCl3): δ 6.91 (d, J = 9.1 Hz, 1H, NH), 5.70 (dd, J = 4.3, 9.2 Hz, 1H, NHCH), 5.55 (d, J =
4.3 Hz, 1H, SCH), 4.62 (ABq, J = 23.7 Hz, 2H, CH2), 4.44 (s, 1H, NCH), 2.18 (s, 3H, CH3),
1.68 (s, 3H, CH3), 1.59 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ 207.46, 173.33, 170.53,
166.79, 70.70, 67.45, 64.71, 62.74, 57.67, 31.29, 27.03, 20.65
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(R)-2-((2R,4S)-4-((Benzhydryloxy)carbonyl)-5,5-dimethylthiazolidin-2-yl)-2-(2-hydroxya
cetamido)acetic acid (82)

This compound was prepared with modification to the procedure by Nicolaou et al.66 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 68 (174 mg, 0.37 mmol) and 1,2-dichloroethane (10 mL). Trimethyltin hydroxide
(179 mg, 1.11 mmol) was added in one portion. The reaction mixture was heated to 80 ˚C,
and allowed to stir at the same temperature for 6 h. The mixture was then concentrated under
reduced pressure, and the residue was diluted with ethyl acetate (15 mL). The organic layer
was washed with a solution of saturated ammonium chloride (8 mL), and brine (8 mL). The
organic layer was then dried with magnesium sulfate, filtered, and concentrated under
reduced pressure. The crude product was purified by flash column chromatography
(hexane:acetone = 1:1 )to yield pure product (50 mg, 30% yield). Major: 1H NMR (400 MHz,
CDCl3): δ 7.35 (m, 10H, ArH), 6.95 (s, 1H, CHPh2), 6.91 (t, J = 5.3 Hz, 1H, CONH), 4.78
(dd, J = 6.4, 3.7 Hz, 1H, SCH), 4.10 (s, 2H, CH2), 3.92 (ddd, J = 14.2, 7.6, 3.7 Hz, 1H,
CONHCH), 3.73 (s, 1H, NHCH), 3.36 (ddd, J = 4.6, 6.4, 14.2 Hz, 1H, NH), 1.63 (s, 3H,
CH3), 1.01 (s, 3H, CH3). Minor: 1HNMR (400 MHz, CDCl3): δ 7.33 (m, 10H, ArH), 6.97 (s,
1H. CHPh2), 6.87 (br, 1H, CONH), 4.65 (dd, J = 9.6, 4.6 Hz, 1H, SCH), 4.06 (s, 2H, CH2),
3.79 (s, 1H, NHCH), 3.60 (ddd, J = 13.1, 8.0, 4.6 Hz, 1H, CONHCH), 3.17 (ddd, J = 13.8,
9.6, 4.1 Hz, 1H, NH), 1.62 (s, 1H, CH3), 0.98 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ
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172.10, 171.34, 168.55, 168.28, 139.23, 139.13, 128.63, 128.61, 128.59, 128.55, 128.47,
128.38, 128.16, 128.10, 127.74, 127.67, 126.87, 78.28, 78.14, 74.08, 71.19, 66.29, 64.87,
62.18, 62.07, 59.35, 59.21, 44.81, 42.03, 28.68, 27.98, 27.93, 27.08. HRMS (ESI): [M+H]+
m/z calcd for C23H27N2O6S: 459.1590; found 459.1587.

(2R,4S)-2-((R)-Carboxy(2-hydroxyacetamido)methyl)-5,5-dimethylthiazolidine-4-carbox
ylic acid (83)

This compound was prepared with modification to the procedure by Kametani et al.85 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 82 (35 mg, 0.08 mmol) and formic acid (1 mL). The reaction was allowed to stir at
45 ˚C for 0.5 h. The reaction mixture was concentrated under reduced pressure. The
remaining residue was diluted with water (1 mL), and washed with ethyl acetate (1 mL). The
aqueous layer was dried to yield a light-yellow oil (12mg, 54% yield). Major: 1H NMR (400
MHz, Methanol-d4): δ 4.76 (m, 1H, SCH), 3.97 (s, 2H, CH2), 3.78 (s, 1H, NHCH), 3.69 (dd,
J = 14.1, 4.0 Hz, 1H, CONHCH), 3.39 (d, J = 3.8 Hz, 1H, NH), 1.64 (s, 3H, CH3), 1.29 (s,
3H, CH3). Minor: 1H NMR (400 MHz, Methanol-d4): δ 4.74 (m, 1H, SCH), 4.00 (s, 2H,
CH2), 3.65 (s, 1H, NHCH), 3.50 (dd, J = 14.1, 7.2 Hz, 1H, CONHCH), 3.36 (d, J = 6.6 Hz,
1H, NH), 1.64 (s, 3H, CH3), 1.31 (s, 3H, CH3). 13C NMR (100 MHz, Methanol-d4): δ 174.56,
174.06, 170.42, 170.13, 73.97, 71.43, 64.85, 63.89, 61.16, 61.14, 57.65, 57.07, 44.11, 41.75,
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27.75, 27.15, 26.94, 26.14. HRMS (ESI): [M+H]+ m/z calcd for C10H17N2O6S: 293.0802;
found 293.0558.

Benzhydryl (2S,5R)-6-bromo-3,3-dimethyl-6-(2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3,8-di
siladecan-5-yl)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (88)

This compound was prepared with modification to the procedure by Fujimoto et al.73 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the mixture of compound 34 (388 mg, 0.6 mmol), and dichloromethane (10 mL), and was
cooled to 0 ˚C. tert-Butyldimethylsilyl chloride (373 mg, 2.4 mmol) and imidazole (311 mg,
4.8 mmol) was added in one portion. The reaction mixture was warmed to room temperature,
and allowed to stir for 24 h. The reaction mixture was then washed with water (10 mL), and
brine (10 mL). The organic layer was dried with sodium sulfate, filtered, and concentrated
under reduced pressure. The crude product was purified by flash column chromatography
(hexane:ethyl acetate = 20:1) to yield the product 88. (301 mg, 65 % yield). Major: 1H NMR
(400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.92 (s, 1H, CHPh2), 5.92 (s, 1H, SCH), 4.56 (s,
1H, NCH), 4.14 (m, 2H, CH2), 3.82 (dd, J = 10.9, 1.8 Hz, 1H, CH2CH), 1.64 (s, 3H, CH3),
1.23 (s, 3H, CH3), 0.91 (s, 9H, C(CH3)3), 0.76 (s, 9H, C(CH3)3), 0.07 (s, 3H, SiCH3), 0.07 (s,
3H, SiCH3), 0.06 (s, 6H, Si(CH3)2). Minor: 1H NMR (400 MHz, CDCl3): δ 7.35 (m, 10H,
ArH), 6.94 (s, 1H, CHPh2), 5.64 (s, 1H, SCH), 4.59 (s, 1H, NCH), 4.15 (dd, J = 7.7, 5.2 Hz,
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1H, CHaHb), 3.83 (dd, J = 10.2, 7.7 Hz, 1H, CHaHb), 3.65 (dd, J = 10.2, 5.3 Hz, 1H, CH2CH),
1.66 (s, 3H, CH3), 1.25 (s, 3H, CH3), 0.90 (s, 9H, C(CH3)3), 0.86 (s, 9H, C(CH3)3), 0.12 (s,
3H, SiCH3), 0.10 (s, 3H, SiCH3), 0.04 (s, 6H, Si(CH3)2). 13C NMR (100 MHz, CDCl3): δ
169.50, 169.16, 166.58, 166.36, 139.32, 139.24, 139.14, 139.12, 128.58, 128.57, 128.50,
128.35, 128.23, 128.16, 128.07, 127.48, 127.17, 127.00, 78.35, 78.25, 76.14, 75.01, 74.07,
73.33, 71.67, 71.31, 70.02, 69.92, 65.35, 64.91, 64.32, 63.89, 33.43, 32.78, 26.14, 26.00,
25.73, 25.50, 18.39, 18.25, 18.06, 17.95, -4.26, -4.39, -4.87, -5.33, -5.41, -5.45, -5.50, -5.64.
HRMS (ESI): [M+H]+ m/z calcd for C35H53NO5SBrSi2: 734.2366; found 734.2361.

Benzhydryl (2S,5R)-3,3-dimethyl-6-(2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3,8-disiladecan
-5-yl)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (90b)

This compound was prepared with modification to the procedure by Testero et al.53 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 88 (150 mg, 0.2 mmol) and methanol (10 mL), and was cooled to 0 ˚C.
Tri-n-butylphosphine (0.1 mL, 0.3 mmol, 97%) was added dropwise by syringe in 1 min. The
reaction mixture was allowed to stir for 1 h. The reaction mixture was then concentrated
under reduced pressure, and the residual oil was purified by flash column chromatography
(hexane:ethyl acetate = 50:1 to 35:1) to yield a light-yellow solid (58 mg, 43% yield). 1H
NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.93 (s, 1H, CHPh2), 5.42 (d, J = 1.8 Hz, 1H,
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SCH), 4.54 (s, 1H, NCH), 4.12 (ddd, J = 6.7, 4.6, 2.8 Hz, 1H, CH2CH), 3.59 (dd, J = 4.7, 1.8
Hz, 1H, COCH), 3.54 (m, 2H, CH2), 1.60 (s, 3H, CH3), 1.23 (s, 3H, CH3), 0.89 (s, 9H,
C(CH3)3), 0.80 (s, 9H, C(CH3)3), 0.06 (s, 3H, SiCH3), 0.05 (s, 6H, Si(CH3)2), 0.02 (s, 3H,
SiCH3). HRMS (ESI): [M+H]+ m/z calcd for C35H54NO5SSi2: 656.3261; found 656.3259.

3-((tert-Butyldimethylsilyl)oxy)propan-1-ol (93)

This compound was prepared according to the procedure by Cornil et al80. An oven-dried
250-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
1,3-propanediol 92 (6.09 g, 80.0 mmol), dichloromethane (80 mL), and was cooled to 0 ˚C.
Triethylamine (6.7 mL, 48 mmol) was added dropwise by syringe in 7 min.
tert-Butyldimethylsilyl chloride (6.02g, 40 mmol) was added quickly in one portion. The
reaction mixture was warmed to room temperature and allowed to stir for 16 h. The reaction
was quenched with a solution of saturated sodium bicarbonate (20 mL). The aqueous layer
was extracted with dichloromethane (2 x 20 mL). The combined organic layers were washed
with water (10 mL) and brine (10 mL), dried with sodium sulfate, filtered, and concentrated
under reduced pressure. The crude clear oil was purified by flash column chromatography
(hexane:EtOAc = 8:1 to 6:1 to 4:1) to yield a colorless oil (7.30 g, 48% yield). 1H NMR (400
MHz, CDCl3): δ 3.84 (t, J = 5.6 Hz, 2H, TBSOCH2), 3.81 (q, J = 5.4 Hz, 2H, HOCH2), 2.58
(t, J = 5.4 Hz, 1H, OH), 1.78 (p, J = 5.6 Hz, 2H, CH2CH2CH2), 0.90 (s, 9H, C(CH3)3), 0.08 (s,
6H, Si(CH3)2).
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3-((tert-Butyldimethylsilyl)oxy)propanal (94)

This compound was prepared with modification to the procedure by Chen et al. An
oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with 93
(2.38g, 12.5 mmol) and dichloromethane (20 mL), and was cooled to 0 ˚C. Dess-Martin
periodinane (5.58g, 13.2 mmol) was added quickly in one portion. The reaction mixture was
stirred for 4 h while slowly warming to room temperature. The reaction mixture was filtered
through a pad of Celite. The filtrate was concentrated under reduced pressure. The crude clear
liquid was purified by flash column chromatography (hexane:ethyl acetate = 20:1 to 15:1 to
10:1) to yield a clear oil (2.10g, 89% yield). 1H NMR (400 MHz, CDCl3): δ 9.80 (t, J = 2.1
Hz, 1H, CHO), 3.99 (t, J = 6.0 Hz, 2H, TBSOCH2), 2.60 (td, J = 6.0, 2.1 Hz, 2H, COCH2),
0.88 (s, 9H, C(CH3)3), 0.07 (s, 6H, Si(CH3)2).

Benzhydryl (2S,5R)-6-bromo-6-(3-((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-3,3-d
imethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (95)

This compound was prepared with modification to the procedure by Testero et al.53 An
oven-dried 100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
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compound 33 (0.95 g, 1.8 mmol) and anhydrous tetrahydrofuran (35 mL), and was cooled to
-78 ˚C. Ethylmagnesium bromide (0.9 mL, 2.7 mmol, 3M in THF) was added dropwise by
syringe in 1 min. The reaction mixture was stirred for 2 h. Anhydrous aldehyde 94 (510 mg,
2.7 mmol) was added dropwise by syringe over 1 min. The reaction mixture was allowed to
stir for another 3 h. The reaction was quenched with a solution of saturated ammonium
chloride (10 mL) at -78 ˚C, warmed to room temperature, and concentrated under reduced
pressure. The residue was diluted with water (5 mL) and ethyl acetate (15 mL). The aqueous
layer was extracted with ethyl acetate (3 x 15 mL). The combined organic layers were
washed with a solution of sodium bicarbonate (10 mL, 5%), and brine (10 mL). The organic
layer was then dried with magnesium sulfate, filtered, and concentrated under reduced
pressure. The crude residue was purified by flash column chromatography (hexane:ethyl
acetate = 10:1 to 5:1) to yield a light yellow colored oil (546 mg, 49% yield). 1H NMR (400
MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.93 (s, 1H, CHPh2), 5.62 (s, 1H, SCH), 4.61 (s, 1H,
NCH), 4.31 (ddd, J = 9.5, 3.5, 2.3 Hz, 1H, HOCH), 3.94 – 3.75 (m, 2H, TBSOCH2), 3.05 (d,
J = 3.6 Hz, 1H, OH), 1.85 (dddd, J = 13.8, 10.0, 6.2, 4.1 Hz, 1H, CHCHaHb), 1.66 (m, 1H,
CHCHaHb), 1.63 (s, 3H, CH3), 1.26 (s, 3H, CH3), 0.90 (s, 9H, C(CH3)3), 0.07 (s, 6H,
Si(CH3)2). 13C NMR (100 MHz, CDCl3): δ 168.82, 166.01, 139.01, 138.94, 128.63, 128.62,
128.39, 128.29, 127.38, 127.09, 78.49, 74.77, 71.32, 69.28, 68.10, 64.71, 59.98, 34.73, 33.54,
25.92, 25.64, 18.24, -5.42, -5.49. HRMS (ESI): [M+H]+ m/z calcd for C30H41NO5SBrSi:
634.1658; found 634.1646.
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Benzhydryl (2S,5R)-6-(3-((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-3,3-dimethyl-7
-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (96)

This compound was prepared with modification to the procedure by Testero et al.53 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the compound 95 (340 mg, 0.5 mmol) and methanol (10 mL), and was cooled to 0 ˚C. The
tri-n-butylphosphine (0.2 ml, 0.75 mmol, 97%) was added dropwise by syringe in 1 min. The
reaction mixture was allowed to stir for 1 h. The reaction mixture was then concentrated
under reduced pressure, and the residual oil was purified by flash column chromatography
(hexane:ethyl acetate = 5:1) to yield a light-yellow oil (247 mg, 83% yield). 1H NMR (400
MHz, CDCl3): δ 7.35 (m, 10H, ArH), 6.93 (s, 1H, CHPh2), 5.36 (d, J = 1.6 Hz, 1H, SCH),
4.56 (s, 1H, NCH), 4.27 (ddt, J = 8.8, 7.7, 2.4 Hz, 1H, HOCH), 3.96 (d, J = 2.6 Hz, 1H, OH),
3.88 (m, 2H, TBSOCH2), 3.37 (dd, J = 7.7, 1.7 Hz, 1H, COCH), 1.83 (m, 2H, CHCH2), 1.61
(s, 3H, CH3), 1.24 (s, 3H, CH3), 0.90 (s, 9H, C(CH3)3), 0.09 (s, 3H, SiCH3), 0.09 (s, 3H,
SiCH3).

13

C NMR (100 MHz, CDCl3): δ 172.38, 166.90, 139.30, 139.20, 128.56, 128.53,

128.26, 128.10, 127.53, 127.02, 78.13, 70.47, 69.76, 67.02, 65.44, 64.27, 62.77, 36.08, 32.82,
26.03, 25.82, 18.05, -5.58, -5.62. HRMS (ESI): [M+H]+ m/z calcd for C30H42NO5SSi:
556.2553; found 556.2542.
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Benzhydryl (2S,5R)-3,3-dimethyl-6-(2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaun
decan-5-yl)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (97)

This compound was prepared with modification to the procedure by Fujimoto et al.73 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the compound 96 (124 mg, 0.2 mmol), and dichloromethane (10 mL), and was cooled to 0 ˚C.
tert-Butyldimethylsilyl chloride (128 mg, 0.8 mmol) and imidazole (169 mg, 0.8 mmol) was
added in one portion. The reaction mixture was warmed to room temperature, and was
allowed to stir for 24 h. The reaction mixture was washed with water (10 mL), and brine (10
mL). The organic layer was then dried with sodium sulfate, filtered, and concentrated under
reduced pressure. The crude product was purified by flash column chromatography
(hexane:ethyl acetate = 10:1) to yield a light-yellow solid (43 mg, 29 % yield). Major: 1H
NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 6.92 (s, 1H, CHPh2), 5.24 (d, J = 1.9 Hz, 1H,
SCH), 4.55 (s, 1H, NCH), 4.23 (m, 1H, TBSOCH), 3.69 (t, J = 6.1 Hz, 2H, TBSOCH2), 3.57
(dd, J = 1.9, 4.4 Hz, 1H, COCH), 1.83 (m, 2H, CHCH2), 1.60 (s, 3H, CH3), 1.24 (s, 3H, CH3),
0.88 (s, 9H, C(CH3)3), 0.84 (s, 9H, C(CH3)3), 0.05 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3), 0.04
(s, 6H, Si(CH3)2). Minor: 1H NMR (400 MHz, CDCl3): δ 7.30 (m, 10H, ArH), 6.92 (s, 1H,
CHPh2), 5.33 (d, J = 1.9 Hz, 1H, SCH), 4.55 (s, 1H, NCH), 4.27 (m, 1H, TBSOCH), 3.65 (m,
2H, TBSOCH2), 3.47 (dd, J = 4.1, 1.9 Hz, 1H, COCH), 1.75 (qd, J = 6.2, 3.1 Hz, 2H,
CHCH2), 1.59 (s, 3H, CH3), 1.24 (s, 3H, CH3), 0.89 (s, 9H, C(CH3)3), 0.82 (s, 9H, C(CH3)3),
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0.07 (s, 6H, Si(CH3)2), 0.06 (s, 3H, SiCH3), 0.02 (s, 3H, SiCH3).

13

C NMR (100 MHz,

CDCl3): δ 172.76, 172.31, 166.87, 166.84, 139.29, 139.24, 128.54, 128.48, 128.22, 128.05,
127.55, 127.09, 78.11, 78.04, 69.68, 69.63, 68.17, 67.47, 66.08, 65.16, 65.09, 63.66, 63.32,
59.23, 59.05, 39.20, 37.86, 33.21, 33.09, 26.00, 25.96, 25.93, 25.72, 18.28, 18.24, 17.97,
-4.51, -4.55, -4.68, -4.81, -5.32, -5.35. HRMS (ESI): [M+H]+ m/z calcd for C36H56NO5SSi2:
670.3418; found 670.3423.

(2R,4S)-2-((2S)-3,5-bis((tert-Butyldimethylsilyl)oxy)-1-methoxy-1-oxopentan-2-yl)-5,5-di
methylthiazolidine-4-carboxylic acid (98)

An oven-dried 50-ml round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with compound 97 (43 mg, 0.06 mmol) and methanol (5 mL), and was cooled to 0 ˚C.
Lithium hydroxide (3 mg, 0.12 mmol) was added in one portion. The reaction mixture was
allowed to stir for 5 min. Immediately thereafter, the reaction was quenched with a solution
of saturated ammonium chloride (5 mL). The remaining methanol was removed under
reduced pressure. The residue was extracted with ethyl acetate (3 x 10 mL). The combined
organic layers were dried with magnesium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:acetone =
3:1) to yield a light-yellow solid. (12 mg, 35% yield). Major: 1H NMR (400 MHz, CDCl3): δ
5.22 (d, J = 1.8 Hz, 1H, SCH), 4.47 (s, 1H, NHCH), 4.22 (td, J = 6.5, 3.9 Hz, 1H, TBSOCH),
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3.73 (s, 3H, OCH3), 3.69 (t, J = 6.1 Hz, 2H, TBSOCH2), 3.55 (dd, J = 3.9, 1.8 Hz, 1H,
TBSOCHCH), 1.86 (m, 2H, CHCH2), 1.62 (s, 3H, CH3), 1.44 (s, 3H, CH3), 0.89 (s, 9H,
C(CH3)3), 0.89 (s, 9H, C(CH3)3), 0.10 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3), 0.04 (s, 6H,
Si(CH3)2). Minor: 1H NMR (400 MHz, CDCl3): δ 5.31 (d, J = 1.8 Hz, 1H, SCH), 4.44 (s, 1H,
NHCH), 4.28 (td, J = 6.1, 3.3 Hz, 1H, TBSOCH), 3.73 (s, 3H, OCH3), 3.65 (m, 2H,
TBSOCH2), 3.44 (dd, J = 3.3, 1.8 Hz, 1H, TBSOCHCH), 1.71 (m, 2H, CHCH2), 1.62 (s, 3H,
CH3), 1.45 (s, 3H, CH3), 0.89 (s, 9H, C(CH3)3), 0.89 (s, 9H, C(CH3)3), 0.07 (s, 3H, SiCH3),
0.07 (s, 3H, SiCH3), 0.05 (s, 6H, Si(CH3)2). 13C NMR (100 MHz, CDCl3): δ 172.13, 168.30,
69.65, 67.18, 66.32, 63.81, 59.26, 52.06, 38.10, 33.01, 26.34, 25.93, 25.71, -4.82, -5.36.

Benzhydryl (2R,4S)-2-((2S)-5-((tert-butyldimethylsilyl)oxy)-3-hydroxy-1-methoxy-1-ox
opentan-2-yl)-5,5-dimethylthiazolidine-4-carboxylate (99)

An oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with compound 96 (390 mg, 0.7 mmol) and methanol (10 mL), and was cooled to 0 ˚C.
Lithium hydroxide (34 mg, 1.4 mmol) was added to the reaction mixture in one portion. The
reaction mixture was allowed to stir for 5 min. Immediately thereafter, the reaction was
quenched with a solution of saturated ammonium chloride (10 mL). The remaining methanol
was removed under reduced pressure. The residue was extracted with ethyl acetate (3 x 10
mL). The combined organic layers were dried with magnesium sulfate, filtered, and
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concentrated under reduced pressure. The crude product was purified by flash column
chromatography (hexane:acetone = 3:1) to yield a light-yellow solid. (314 mg, 76% yield).
1

H NMR (400 MHz, CDCl3): δ 7.35 (m, 10H, ArH), 6.96 (s, 1H, CHPh2), 5.16 (m, 1H, SCH),

4.01 (m, 1H, HOCH), 3.81 (m, 3H, TBSOCH2, NHCH), 3.53 (br, 1H, NH), 3.27 (d, J = 6.3
Hz, 1H, OH), 2.67 (dd, J = 9.9, 3.4 Hz, 1H, COCH), 1.66 (m, 2H, CHCH2), 1.57 (s, 3H, CH3),
1.00 (s, 3H, CH3), 0.88 (s, 9H, C(CH3)3), 0.06 (s, 6H, Si(CH3)2). 13CNMR (100 MHz, CDCl3):
δ 173.14, 168.63, 139.40, 139.29, 128.56, 128.52, 128.36, 128.03, 127.76, 126.84, 77.90,
72.12, 69.51, 66.01, 61.20, 59.47, 58.91, 51.74, 38.07, 28.30, 26.94, 25.90, 18.22, -5.44,
-5.46. HRMS (ESI): [M+H]+ m/z calcd for C31H46NO6SSi: 588.2815; found 588.2819.

Benzhydryl (2R,4S)-2-((2S)-3,5-dihydroxy-1-methoxy-1-oxopentan-2-yl)-5,5-dimethylth
iazolidine-4-carboxylate (100)

This compound was prepared with modification to the procedure by Kaburagi et al.75 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 99 (314 mg, 0.5 mmol) and anhydrous tetrahydrofuran (15 mL), and was cooled to
0 ˚C. Tetra-n-butylammonium fluoride (1 mL, 1.0 mmol) was added dropwise by syringe in 1
min. The reaction mixture was allowed to stir for 1 h. The reaction mixture was then
quenched with a solution of saturated ammonium chloride (10 mL). The aqueous layer was
extracted with ethyl acetate (4 x 15 mL). The combined organic layers were dried with
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magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was
purified by flash column chromatography (hexane:acetone = 3:1) to yield a light yellow oil
(186 mg, 74% yield). Major: 1H NMR (400 MHz, CDCl3): δ 7.35 (m, 10H, ArH), 6.98 (s, 1H,
CHPh2), 4.93 (br, 1H, SCH), 4.27 (ddd, J = 9.2, 5.7, 2.9 Hz, 1H, HOCH), 3.81 (m, 2H,
TBSOCH2), 3.72 (s, 3H, OCH3), 3.68 (m, 1H, NHCH), 2.97 (t, J = 5.8 Hz, 1H, COCH), 2.57
(br, 1H, OH), 1.80 (m, 2H, CHCH2), 1.63 (s, 3H, CH3), 0.96 (s, 3H, CH3). Minor:

1

H NMR

(400 MHz, CDCl3): δ 7.30 (m, 10H, ArH), 6.95 (s, 1H, CHPh2), 5.11 (d, J = 8.0 Hz, 1H,
SCH), 4.21 (ddd, J = 9.6, 6.5, 2.5 Hz, 1H, HOCH), 3.76 (td, J = 5.0, 2.2 Hz, 2H, TBSOCH2),
3.69 (s, 3H, OCH3), 3.67 (m, 1H, NHCH), 2.90 (dd, J = 8.0, 6.6 Hz, 1H, COCH), 2.57 (s, 1H,
OH), 1.68 (ddt, J = 5.5, 4.2, 3.0 Hz, 2H, CHCH2), 1.58 (s, 3H, CH3), 1.02 (s, 3H, CH3). 13C
NMR (100 MHz, CDCl3): δ 172.42, 171.51, 168.87, 168.19, 139.33, 139.23, 128.61, 128.59,
128.56, 128.40, 128.13, 128.06, 127.78, 127.65, 126.91, 126.80, 78.12, 78.05, 73.50, 72.27,
71.40, 71.30, 65.19, 64.95, 61.44, 61.09, 59.11, 58.51, 58.29, 55.94, 52.20, 51.86, 35.82,
29.02, 28.31, 27.91, 26.57. HRMS (ESI): [M+H]+ m/z calcd for C25H32NO6S: 474.1950;
found 474.1951.

benzhydryl (2R,4S)-2-((3S,4R)-4-hydroxy-2-oxotetrahydro-2H-pyran-3-yl)-5,5-dimethyl
thiazolidine-4-carboxylate (102)

This compound was prepared with modification to the procedure by Nicolaou et al.66 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
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and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 101 (73 mg, 0.17 mmol) and 1,2-dichloroethane (10 mL). Trimethyltin hydroxide
(92 mg, 0.51 mmol) was added in one portion. The reaction mixture was heated to 80 ˚C, and
allowed to stir for 6 h. The mixture was then concentrated under reduced pressure, and the
residue was diluted with ethyl acetate (5 mL). The organic layer was washed with a solution
of saturated ammonium chloride (5 mL), and brine (5 mL). The organic layer was dried with
magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was
purified by flash column chromatography to yield a light-yellow oil (22 mg, 32% yield). 1H
NMR (400 MHz, CDCl3): δ 7.35 (m, 10H, ArH), 6.98 (s, 1H, CHPh2), 5.07 (d, J = 4.7 Hz, 1H,
COCH), 4.42 (ddd, J = 11.5, 6.5, 3.8 Hz, 1H, CO2CHaHb), 4.24 (ddd, J = 11.7, 8.4, 3.5 Hz,
1H, , CO2CHaHb), 4.01 (td, J = 7.7, 5.3 Hz, 1H, HOCH), 3.71 (s, 1H, NHCH), 3.00 (dd, J =
8.0, 4.7 Hz, 1H, SCH), 2.15 (m, 1H, HOCHCHaHb), 1.91 (dtd, J = 14.2, 8.0, 3.8 Hz, 1H,
HOCHCHaHb), 1.64 (s, 3H, CH3), 1.05 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ 170.66,
168.12, 139.34, 139.32, 128.60, 128.53, 128.32, 128.05, 127.65, 126.93, 78.00, 73.91, 67.92,
65.96, 65.20, 58.79, 53.36, 32.09, 28.89, 27.46. HRMS (ESI): [M+H]+ m/z calcd for
C24H28NO5S: 442.1688; found 442.1682.

2-(1,3-Dioxoisoindolin-2-yl)acetyl chloride (107)

This compound was prepared with modification to the procedure by Decuyper et al.77 An
oven-dried 250-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
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and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
2-(1,3-dioxoisoindolin-2-yl)acetic

acid
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(1.00

g,

4.9

mmol)

and

anhydrous

dichloromethane (50 mL). Oxalyl chloride (0.6 mL, 7.5 mmol) was added dropwise by
syringe in 1 min, and dimethylformamide (2 drops) was added to the reaction mixture at
room temperature. The reaction mixture was allowed to stir for 1 h. The reaction mixture was
then concentrated under reduced pressure to yield a white solid (1.07 g, 98% yield) without
further purifications. 1H NMR (400 MHz, CDCl3): δ 7.92 (dd, J = 5.5, 3.0 Hz, 2H, ArH), 7.79
(dd, J = 5.5, 3.0 Hz, 2H, ArH), 4.83 (s, 2H, CH2).

(2S,5R,6R)-6-(2-(1,3-Dioxoisoindolin-2-yl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabic
yclo[3.2.0]heptane-2-carboxylic acid (108)

This compound was prepared with modification to the procedure by Solovskii et al.62 An
oven-dried 250-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
6-APA (1.08 g, 5 mmol), phosphate buffer solution (100 mL, 0.1 M, pH 6.6), and a solution
of sodium bicarbonate (20 mL, 10%), and was cooled to 0 ˚C. A solution of
Phthalimidoacetyl chloride (1.68 g, 7.5 mmol) in acetone (20 mL) was added dropwise by
addition funnel in 20 min. The reaction mixture was allowed to stir for 20 min. After reaction
completion, the reaction mixture was then extracted with diethyl ether (2 x 10 mL). The
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aqueous layer was acidified with 1 N hydrochloric acid to pH 2.0. The remaining aqueous
layer was extracted with ethyl acetate (3 x 20 mL). The combined organic layers were dried
with sodium sulfate, filtered, and concentrated under reduced pressure to yield a light-yellow
solid (1.88 g, 93% yield) without further purifications. 1H NMR (400 MHz, CDCl3): δ 9.45
(br, 1H, CO2H), 7.84 (dd, J = 5.4, 3.1 Hz, 2H, ArH), 7.71 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 7.11
(d, J = 8.6 Hz, 1H, NH), 5.65 (dd, J = 8.6, 4.2 Hz, 1H, NHCH), 5.48 (d, J = 4.2 Hz, 1H,
SCH), 4.45 (ABq, J = 16.0 Hz, 2H, CH2), 4.38 (s, 1H, NCH), 1.59 (s, 3H, CH3), 1.52 (s, 3H,
CH3).

13

C NMR (100 MHz, CDCl3): δ 173.48, 170.12, 167.66, 167.42, 166.54, 134.22,

131.83, 123.56, 70.41, 67.55, 64.45, 58.55, 40.20, 30.87, 26.88. HRMS (ESI): [M+H]+ m/z
calcd for C18H18N3O6S: 404.0916; found 404.0912.

Benzhydryl (2S,5R,6R)-6-(2-(1,3-dioxoisoindolin-2-yl)acetamido)-3,3-dimethyl-7-oxo-4thia-1-azabicyclo[3.2.0]heptane-2-carboxylate (109)

This compound was prepared according to the procedure by Palena et al.52 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound 108 (404 mg, 1 mmol), acetone (2 mL), and anhydrous chloroform (5.6 mL), and
was cooled to 0 ˚C. Triethylamine (0.3 mL, 1.2 mmol) was added dropwise. Then a solution
of tetra-n-butylammonium iodide (147 mg, 0.4 mmol) and bromodiphenylmethane (308 mg,
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1.2 mmol) in chloroform (1.7 mL) was added dropwise in 2 min. The reaction mixture was
allowed to stir at reflux for 6 h. The reaction mixture was then diluted with ethyl acetate (100
mL) and washed with a solution of 1 N hydrochloric acid (2 x 5 mL), sodium bicarbonate (2
x 5 mL, 5%) and brine (5 mL). The organic layer was dried with sodium sulfate, filtered, and
concentrated under reduced pressure. The crude product was purified by flash column
chromatography (hexane:acetone = 3:1) to yield a light-yellow solid (33 mg, 6% yield). 1H
NMR (400 MHz, CDCl3): δ 7.89 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 7.75 (dd, J = 5.4, 3.1 Hz, 2H,
ArH), 7.35 (m, 10H, ArH), 6.94 (s, 1H, CHPh2), 6.53 (d, J = 8.8 Hz, 1H, NH), 5.69 (dd, J =
8.9, 4.2 Hz, 1H, NHCH), 5.57 (d, J = 4.3 Hz, 1H, SCH), 4.54 (s, 1H, NCH), 4.43 (ABq, J =
31.0 Hz, 2H, CH2), 1.62 (s, 3H, CH3), 1.26 (s, 3H, CH3).

13

C NMR (100 MHz, CDCl3): δ

172.95, 167.53, 166.61, 165.61, 134.35, 131.88, 128.66, 128.60, 128.44, 128.24, 127.53,
126.97, 123.72, 78.49, 70.52, 68.05, 65.15, 58.81, 40.66, 32.19, 26.60. HRMS (ESI):
[M+Na]+ m/z calcd for C31H28N3O6S: 570.1699; found 570.1705.

Benzhydryl (2R,4S)-2-((R)-1-(2-(1,3-dioxoisoindolin-2-yl)acetamido)-2-methoxy-2-oxoet
hyl)-5,5-dimethylthiazolidine-4-carboxylate (110)

An oven-dried 50-ml round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with compound 109 (100 mg, 0.18 mmol) and methanol (5 mL), and was cooled to 0 ˚C.
Lithium hydroxide (4 mg, 0.18 mmol) was added in one portion. The reaction mixture was
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allowed to stir at the same temperature for 5 min. Immediately thereafter, the reaction was
quenched with a solution of saturated ammonium chloride (5 mL). The remaining methanol
was removed under reduced pressure. The residue was extracted with ethyl acetate (3 x 10
mL). The combined organic layers were dried with sodium sulfate, filtered, and concentrated
under reduced pressure. The crude product was purified by flash column chromatography
(hexane:acetone = 3:1) to yield a light-yellow solid. (50 mg, 47% yield). 1H NMR (400 MHz,
CDCl3): δ 7.82 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 7.69 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 7.36 (m,
10H, ArH), 6.94 (s, 1H, CHPh2), 6.58 (d, J = 8.1 Hz, 1H, NH), 5.10 (d, J = 4.2 Hz, 1H, SCH),
4.61 (dd, J = 8.1, 4.2 Hz, 1H, CONHCH), 4.43 (d, J = 4.5 Hz, 2H, CH2), 3.85 (s, 1H, OCH3),
3.74 (s, 1H, NHCH), 1.58 (s, 3H, CH3), 0.97 (s, 3H, CH3).

13

C NMR (100 MHz, CDCl3): δ

170.12, 168.67, 167.59, 166.21, 139.22, 139.18, 134.19, 131.97, 128.62, 128.58, 128.47,
128.09, 127.83, 126.85, 123.62, 78.31, 72.78, 65.98, 58.99, 57.32, 52.78, 40.77, 26.64, 26.28.
HRMS (ESI): [M+H]+ m/z calcd for C32H32N3O7S: 602.1961; found 602.1958.
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APPENDICES

Appendix

A-Frustrated

Amine/Borane

Lewis

Pair:

A

Pyridine

and

Borabenzene-Derived Azobenzene

A1. Introduction

The Lewis Acids and Bases theory was first proposed by Professor Gilbert Lewis in
1923,1 this could be a good explanation on a classical acid-base adduct formation because of
the interactions between the electron donor (Lewis bases) and electron acceptor (Lewis acids).
The Lewis bases could donate electrons to Lewis acids to form the dative bond (coordinate
covalent bond) as a normal adduct, Such as F3B←NH3.

As early as 1942, an interesting observation was found by Brown.2 He noticed that
the dative bond could be formed between lutidine and boron trifluoride (BF3), but failed with
trimethylborane (BMe3); this could be explained by steric congestion. Until 1996, the first
Frustrated Lewis Pair (FLP) was used as the hydrogenation catalyst to reduce ketone to
alcohol.3 Since 2000s, this area was developing rapidly, and after McCahill’s researches,4
Frustrated Lewis Pair was defined. In chemistry, Frustrated Lewis Pair is a compound or
mixture of combination of Lewis acid and Lewis base, that cannot form a normal adduct
because of the steric hindrance.
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The first FLP hydrogenation was found by Welch.5 In their researches, the
compound A1 was synthesized as a catalyst for hydrogenations. When contacted with
hydrogen gas, compound A1 could activate the hydrogen molecules and carry the hydrogen
to form a zwitterion A2, which could be used as a hydrogen source for hydrogenations. When
adding heat, this zwitterion could lose the hydrogen to form back to the original compound
A1. Because of this characteristic, this compound could be used as the catalyst for
hydrogenations. (Scheme A1.)

Scheme A1. Reversible activation of H2 by using FLPs.5

The Frustrated Lewis Pairs could not only carry the hydrogen for some
hydrogenations but also carry some small molecules as the catalysts. The FLPs was found to
show reactivity to bind with some small molecules to form different zwitterionic compounds,
such as olefins,4 alkynes,6 and cyclopropanes.7 With the development of this area, more
different FPLs could be used to carry more kinds of small molecules (Figure A1).
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Figure A1. Different small molecules that could be carried by FLPs.8

Azobenzene

Azobenzene is a photoswitchable chemical compound composed of two aromatic
rings which are linked by N=N double bond. The first azobenzene was found by
Mitscherlich.9 The N=N double bond between two aromatic rings could be controlled by light
or heat, and the photo-isomerization could be a very fast step which means azobenzene could
be used as light-controlled catalyst for some reactions (Scheme A2).10, 11, 12
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Scheme A2. Isomerization of azobenzene by light or heat.12

Theoretical targets

Based on photoisomerization characteristic of azobenzene, a new kind of FLP A4
could be proposed as the catalyst (Figure A2). We proposed to design new FLPs using
azobenzene core structure. The borabenzene was chosen as Lewis Acid part and the pyridine
was chosen as Lewis Base. When those four R groups are Hs, by using the light,
cis-compound could show aromatic characteristic because of the strong interactions between
B and N. To form the FLPs, this strong interactions (dative bonds) should be inhibited. There
are two possible methods to inhibit the interactions: (1) Increase the steric hindrance by
adding bulky groups on the aromatic rings (R1, R2 = i-Pr or t-Bu); (2) increase the
electrophilic characteristic of B (R3 = -OMe) or decrease nucleophilic characteristic of N (R4
= -NO2). By introducing one or all of those functional groups into this pyridine and
borabenzene-derived azobenzene system, FLPs could be synthesized as the catalysts.

Figure A2. Theoretical azobenzene derived FLPs, which could be controlled by light.
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Results and Discussions

Computations

Computations were conducted for some proposed FLPs using Spartan. Four different
derivatives were proposed for the computations (Figure A3). The first structure A5 was
proposed without any functional groups, because of the interactions between B and N, the
planer structure suggested that the whole system was aromatic. The second structure A6 was
functionalized by using electrophile (-F) on borabenzene and nucleophile (-OMe) on pyridine,
the planer structure proved that the structure was aromatic, because the aromaticity was
strengthened by adding electron withdrawing groups (EWG) on borabenzene ring and
electron donating groups (EDG) on pyridine ring. The third structure A7 was functionalized
by adding bulky groups (-t-Bu) on aromatic rings; the twisted structure suggested that the
steric hindrance could inhibit the dative bond. In this structure the rotation of the pyridine
ring suggested that two t-butyl groups might be too hindered to form FLPs. The last
structures A8 was functionalized by adding nucleophile (-OMe) on borabenzene and
electrophile (-F) on pyridine. The formed trans-compound suggested that the addition of
EWG on pyridine ring and the addition of EDG on borabenzene ring could inhibit the
interactions so much between N and B, which means failure to form FLPs.
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Figure A3. Computation results for four different proposed structures (A5-A8).

Synthesis Route

Based on previous researches, we decided to synthesize the simplest compound A5
to prove that the borane/pyridine azobenzene could show aromaticity without any functional
groups. The synthesis route was proposed in Scheme A3. The first part was to synthesize the
diazo compound of borabenzene. This part of synthesis was proposed with modification of
Hoic’s work.13 Compared to original borabenzene synthesis, according to Kinbara’s work14,
diprotected amino skipped diyne derivative (A22, A23) was synthesized as the starting
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material for borabenzene synthesis. The diprotected amine here was proposed to be converted
into diazo groups for the synthesis of diazo borabenzene A28. The synthesis of final product
A5 was proposed by using diazo borabenzene A28 and lithiumpyridine A30, which could be
synthesized from bromopyridine A29.

Scheme A3. Attempted synthesis of azobenzene derivative A5.
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According to Kinbara’s work, diprotected amines (A11, A12, A13) were synthesized
first. The protecting groups were chosen as -Bn, -Cbz, -Boc, and allyl group (Scheme A4).
The synthesized amines (A11, A12) was conducted to react with iodoacetylene A15, which
was synthesized from A14 (Scheme A4); and compound A16, A17 were synthesized in
42-50%. Based on Kinbara’s work,14 at first, the reaction was attempted with NaHMDS, but
the reaction failed with only starting material collected. When KHMDS was used as base, the
products were successfully synthesized.

Scheme A4. Top: Synthesis of four different starting materials.14, 15

Compounds A22, A23 were synthesized from acetylene A18, A19 and compound
A21. The synthesis of acetylenes A18, A19 were deprotection of TMS acetylene by using
n-Bu4NF,14 and the yields were 91%. Compound A21 was synthesized from compound A20
by using trimethylsilyl chloride (TMSCl),16 and the yield was 26% (Scheme A5). According
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to Caruso’s work,17 compounds A22, A23 were synthesized by cesium carbonate (Cs2CO3)
promoted coupling reaction, and the yields of the skipped diynes were 42-70%.

Scheme A5. Synthesis of alkyne A21.

Since the lack of time, this project was stopped here. The coming steps were
proposed to be the synthesis of diazo borabenzene derivatives A28, and the final step should
be the synthesis of azobenzene A5 between diazo borabenzene A28 and lithiumpyridine A30.
If this azobenzene A5 could be successfully synthesized, this method could be extended to
synthesize different FLPs by adding some functional groups, which are shown before, to
inhibit the interactions between B and N.

Detailed Experimental Procedures

tert-Butyl benzylcarbamate (A11)

This compound was prepared according to the procedure by Lhermet et al.18 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
benzylamine (1.07 g, 1.1 mL, 10 mmol) and dichloromethane (22 mL), and was cooled to 0
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˚C. Triethylamine (1.4 mL, 10 mmol) was added dropwise by syringe in 1 min. A solution of
di-tert-butyldicarbonate (2.18 g, 10 mmol) in dichloromethane (7 mL) was added dropwise in
7 min. The reaction mixture was stirred at room temperature for 6 h. The reaction was
quenched with water (5 mL). The aqueous layer was extracted with dichloromethane (3 x 10
mL). The combined organic layers were washed with brine (10 mL), dried with magnesium
sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by
flash column chromatography (hexane:ethyl acetate = 9:1) to yield a white solid (1.30 g, 63%
yield). 1H NMR (400 MHz, CDCl3): δ 7.30 (m, 5H, ArH), 4.96 (s, 1H, NH), 4.31 (d, J = 6.0
Hz, 2H, CH2), 1.46 (s, 9H, C(CH3)3).

Benzyl benzylcarbamate (A12)

This compound was prepared according to the procedure by Tran et al.19 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
benzylamine (1.07 g, 1.1 mL, 10 mmol) sodium bicarbonate (0.92 g, 11 mmol) and
anhydrous tetrahydrofuran (10 mL). Benzyl chloroformate (2.05 g, 1.7 mL, 12 mmol) was
added dropwise by syringe in 2 min. The reaction mixture was allowed to stir for 2 h. The
reaction mixture was quenched with water (15 mL), and the aqueous layer was extracted with
ethyl acetate (3 x 20 mL). The combined organic layers were dried with sodium sulfate,
filtered, and concentrated under reduced pressure. The crude product was purified by flash
column chromatography (hexane:ethyl acetate = 20:1) to yield a white solid (1.08 g, 45%
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yield). 1H NMR (400 MHz, CDCl3): δ 7.33 (m, 10H), 5.14 (s, 2H, COCH2), 5.04 (s, 1H),
4.40 (d, J = 6.0 Hz, 2H, CH2).

tert-Butyl allylcarbamate (A13)

This compound was prepared according to the procedure by Han et al.20 An oven-dried
50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
allylamine (571 mg, 0.75 mL, 10 mmol) and dichloromethane (10 mL). Triethylamine (1.21 g,
1.7 mL, 12 mmol) was added dropwise by syringe in 2 min. Di-tert-butyldicarbonate (2.18 g,
10 mmol) was added in one portion to the reaction. The reaction mixture was allowed to stir
at room temperature overnight. The reaction mixture was washed with brine (10 mL), dried
with sodium sulfate, filtered, and concentrated under reduced pressure. The crude product
was purified by flash column chromatography (hexane:ethyl acetate = 20:1) to yield a
light-yellow solid. (628 mg, 40% yield) 1H NMR (400 MHz, CDCl3): δ 5.84 (ddt, J = 17.2,
10.6, 5.5 Hz, 1H, H2C=CH), 5.14 (m, 2H, H2C=CH), 4.59 (s, 1H, NH), 3.74 (s, 2H, NHCH2),
1.45 (s, 9H, C(CH3)3).

(Iodoethynyl)trimethylsilane (A15)

This compound was prepared according to the procedure by Schaefer et al.16 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
137

nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
(trimethylsilyl)acetylene (0.97 g, 1.4 mL, 10 mmol) and anhydrous tetrahydrofuran (17 mL),
and was cooled to -78 ˚C. n-Butyllithium (8.2 mL, 2.5 M in THF) was added dropwise by
syringe in 10 min. The reaction mixture was allowed to stir at the same temperature for 15
min. A solution of iodine (2.79 g, 11 mmol) in anhydrous tetrahydrofuran (17 mL) was added
dropwise by additional funnel in 20 min. The reaction mixture was allowed to stir for another
15 min at the same temperature. The reaction was quenched with a solution of saturated
aqueous sodium thiosulfate (17 mL) and extracted with diethyl ether (3 x 17 mL). The
combined organic layers were dried with sodium sulfate, filtered, and concentrated under
reduced pressure to yield a yellow liquid. (640 mg, 28% yield) 1H NMR (400 MHz, CDCl3):
δ 0.18 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 104.20, 20.18, -0.12.

tert-Butyl benzyl((trimethylsilyl)ethynyl)carbamate (A16)

This compound was prepared with modification to the procedure by Kinbara et al.14 An
oven-dried 100-mLl round-bottom flask was equipped with a magnetic stir bar, rubber
septum, and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged
with compound A11 (103 mg, 0.5 mmol) and anhydrous tetrahydrofuran (5 mL), and was
cooled to 0 ˚C. Potassium bis(trimethylsilyl)amide (0.5 mL, 0.5 mmol, 1.0 M in THF) was
added dropwise by syringe. The mixture was allowed to stir for 15 min at the same
temperature. Pyridine (1 mL, 25.0 mmol) was added dropwise by syringe in 2 min, and CuI
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(95 mg, 0.5 mmol) was added in one portion. The reaction mixture was allowed to stir at
room temperature for another 2 h. A solution of 1-iodo-2-(trimethylsilyl)acetylene A15 (135
mg, 0.6 mmol) in anhydrous tetrahydrofuran (4 mL) was added dropwise by syringe in 4 min.
The reaction mixture was allowed to stir at room temperature for another 15 h. The reaction
mixture was quenched with brine (5 mL), and extracted with ethyl acetate (3 x 10 mL). The
combined organic layers were washed with brine (5 mL), dried with magnesium sulfate,
filtered, and concentrated under reduced pressure. The crude product was purified by flash
column chromatography (hexane:ethyl acetate = 20: 1) to yield the product (75 mg, 50%
yield). 1H NMR (400 MHz, CDCl3): δ 7.34 (m, 5H, ArH), 4.54 (s, 2H, CH2), 1.48 (s, 9H,
C(CH3)3), 0.13 (s, 9H, Si(CH3)3).

Benzyl benzyl((trimethylsilyl)ethynyl)carbamate (A17)

This compound was prepared according to the procedure by Kinbara et al.14 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound A12 (120 mg, 0.5 mmol) and anhydrous tetrahydrofuran (5 mL), and was cooled
to 0 ˚C. Potassium bis(trimethylsilyl)amide (0.5 mL, 0.5 mmol, 1.0 M in THF) was added
dropwise by syringe. The mixture was allowed to stir for 15 min at the same temperature.
Pyridine (1 mL, 25.0 mmol) was added dropwise by syringe in 2 min, and CuI (95 mg, 0.5
mmol) was added in one portion. The reaction mixture was warmed to room temperature, and
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was allowed to stir for another 2 h. A solution of alkyne A15 (135 mg, 0.6 mmol) in
anhydrous tetrahydrofuran (4 mL) was added dropwise by syringe in 4 min. The reaction was
allowed to stir at room temperature for another 15 h. The reaction was quenched with brine (5
mL), and extracted with ethyl acetate (3 x 10 mL). The combined organic layers were washed
with brine (5 mL), dried with magnesium sulfate, filtered, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography (hexane:ethyl
acetate = 20: 1) to yield the product (70 mg, 42% yield). 1H NMR (400 MHz, CDCl3): δ 7.33
(m, 10H, ArH), 5.22 (s, 2H, COCH2), 4.61 (s, 2H, CH2), 0.13 (s, 9H, Si(CH3)3).

tert-Butyl benzyl(ethynyl)carbamate (A18)

This compound was prepared with modification to the procedure by Kinbara et al.14 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound A16 (75 mg, 0.25 mmol) and anhydrous tetrahydrofuran (3 mL).
Tetra-n-butylammonium fluoride (0.3 mL, 0.27 mmol, 1.0 M in THF) was added dropwise,
and was cooled to -30 ˚C. The reaction mixture was stirred at the same temperature for 30
min. The reaction was quenched with water (3 mL), and the reaction mixture was extracted
with ethyl acetate (3 x 5 mL). The combined organic layers were washed with water (5 mL),
dried with magnesium sulfate, filtered, and concentrated under reduced pressure. The crude
product was purified by flash column chromatography (hexane:ethyl acetate = 10:1) to yield
a brown oil. (52 mg, 91% yield) 1HNMR (400 MHz, CDCl3): δ 7.34 (m, 5H, ArH), 4.57 (s,
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2H, CH2Ph), 2.76 (s, 2H, CH2), 1.49 (s, 9H, C(CH3)3).

Benzyl benzyl(ethynyl)carbamate (A19)

This compound was prepared with modification to the procedure by Kinbara et al.14 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound A17 (70 mg, 0.2 mmol) and anhydrous tetrahydrofuran (3 mL), and was cooled to
-30 ˚C. Tetra-n-butylammonium fluoride (0.2 mL, 0.22 mmol, 1.0 M in THF) was added
dropwise. The reaction mixture was stirred at the same temperature for 30 min. The reaction
was quenched with water (3 mL), and the reaction mixture was extracted with ethyl acetate (3
x 5 mL). The combined organic layers were washed with water (5 mL), dried with
magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was
purified by flash column chromatography (hexane:ethyl acetate = 10:1) to yield a brown oil.
(50 mg, 91% yield) 1H NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 5.24 (s, 2H, COCH2),
4.64 (s, 2H, CH2), 2.80 (s, 1H, CH).

(3-Bromoprop-1-yn-1-yl)trimethylsilane (A21)

This compound was prepared according to the procedure by Schaefer et al.16 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
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propargyl bromide A20 (2.00 g, 17 mmol, 80% in toluene) and anhydrous tetrahydrofuran
(35 mL), and was cooled to -78 ˚C. n-Butyllithium (5.4 mL, 13.5 mmol, 2.5 M in THF) was
added dropwise by syringe in 5 min. The reaction mixture was allowed to stir for 30 min at
the same temperature. Chlorotrimethylsilane (1.46 g, 1.7 mL, 13.5 mmol.) was added
dropwise by syringe in 2 min at -78 ˚C. The reaction mixture was warmed to room
temperature, and allowed to stir for another 6 h. The reaction was quenched with a solution of
saturated ammonium chloride (10 mL), and extracted with dichloromethane (20 mL). The
organic layer was washed with brine (10 mL), dried with magnesium sulfate, filtered, and
concentrated under reduced pressure. The crude product was filtered through silica gel with
hexane (150 mL), and concentrated under reduced pressure to yield a clear liquid. (850 mg,
26% yield) 1H NMR (400 MHz, CDCl3): δ 3.91 (s, 2H, CH2), 0.18 (s, 9H, Si(CH3)3).

tert-Butyl benzyl(5-(trimethylsilyl)penta-1,4-diyn-1-yl)carbamate (A22)

This compound was prepared with modification to the procedure by Caruso et al. 17 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the ynamide A18 (52 mg, 0.23 mmol) and anhydrous tetrahydrofuran (3 mL). Sodium iodide
(35 mg, 0.23 mmol), Caesium carbonate (73 mg, 0.28 mmol), and copper(I) iodide (44 mg,
0.23 mmol) were added, and the reaction mixture was allowed to stir at room temperature for
25 min. 3-Trimethylsilylpropargyl bromide (63 mg, 0.32 mmol) was then added dropwise in
1 min. The reaction mixture was allowed to stir at room temperature for 16 h. The reaction
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mixture was diluted with diethyl ether (10 mL) and a solution of saturated ammonium
chloride (5 mL). The organic layer was extracted with diethyl ether (2 x 10 mL). The
combined organic layers were washed with brine (10 mL), dried with magnesium sulfate,
filtered, and concentrated under reduced pressure. The crude product was purified by flash
column chromatography (hexane:ethyl acetate = 19:1) to yield a yellow oil. (32 mg, 42%
yield) 1H NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 4.54 (s, 2H, CH2Ph), 3.29 (s, 2H,
CH2), 1.49 (s, 9H, C(CH3)3), 0.16 (s, 9H, Si(CH3)3).

Benzyl benzyl(5-(trimethylsilyl)penta-1,4-diyn-1-yl)carbamate (A23)

This compound was prepared with modification to the procedure by Caruso et al.17 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the ynamide A19 (35 mg, 0.13 mmol) and anhydrous tetrahydrofuran (2 mL). Sodium iodide
(20 mg, 0.13 mmol), Caesium carbonate (51 mg, 0.16 mmol), and copper(I) iodide (25 mg,
0.13 mmol) were added, and the reaction mixture was allowed to stir at room temperature for
25 min. 3-Trimethylsilylpropargyl bromide A21 (35 mg, 0.18 mmol) was then added
dropwise in 1 min. The reaction mixture was allowed to stir at the same temperature for
another 16 h. The reaction mixture was diluted with diethyl ether (10 mL) and a solution of
saturated ammonium chloride (5 mL). The organic layer was extracted with diethyl ether (2 x
10 mL). The combined organic layers were washed with brine (10 mL), dried with
magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was
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purified by flash column chromatography (hexane:ethyl acetate = 19:1) to yield a yellow oil.
(35 mg, 70% yield) 1H NMR (400 MHz, CDCl3): δ 7.34 (m, 10H, ArH), 5.22 (s, 2H, COCH2),
4.62 (s, 2H, CH2), 3.29 (s, 2H, CH2), 0.16 (s, 9H, Si(CH3)3).

Phenyl((trimethylsilyl)ethynyl)iodonium trifluoromethanesulfonate (A31)

This compound was prepared according to the procedure by Tanaka et al.21 An oven-dried
100-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
phenyl-iodanediyl diacetate (1.06 g, 3.3 mmol) and dichloromethane (5 mL), and was cooled
to 0 ˚C. Trifluoromethanesulfonic acid (900 mg, 0.5 mL, 6 mmol) was added dropwise. The
reaction mixture was allowed to stir at the same temperature for 30 min.
Bis(trimethylsilyl)acetylene (510 mg, 3 mmol) was added, and the reaction was allowed to
stir at the same temperature for another 2 h. The reaction mixture was concentrated under
reduced pressure. The residue was poured dropwise into stirred hexane (16 mL). The
resulting solid was collected by vacuum filtration, and washed with diethyl ether (5 mL), and
dried under reduced pressure to yield a white solid. (810 mg, 60% yield) 1H NMR (400 MHz,
CDCl3): δ 8.07 (m, 2H, ArH), 7.68 (m, 1H, ArH), 7.56 (m, 2H, ArH), 0.25 (s, 9H, SiCH3)3).

Benzyl benzyl((trimethylsilyl)ethynyl)carbamate (A17) Method B:
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This compound was prepared according to the procedure by Tanaka et al.21 An oven-dried
100-ml round-bottom flask was equipped with a magnetic stir bar, rubber septum, and
nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
compound A12 (241 mg, 1 mmol) was dissolved in anhydrous tetrahydrofuran (5 mL).
Potassium bis(trimethylsilyl)amide (1 mL, 1 mmol, 1.0 M in THF) was added dropwise by
syringe in 1 min at 0 ˚C. After warming to r.t., compound A31 (495 mg, 1.1 mmol) was added
in one portion. The reaction mixture was allowed to stir for 15 h at room temperature. The
reaction mixture was filtered through a plug of silica gel with ethyl acetate (100 mL). The
organic layer was concentrated under reduced pressure. The crude product was purified by
flash column chromatography (hexane:ethyl acetate = 20:1) to yield a white solid. (47 mg, 14%
yield). 1H NMR (400 MHz, CDCl3): δ 7.33 (m, 10H, ArH), 5.22 (s, 2H, COCH2), 4.61 (s, 2H,
CH2), 0.13 (s, 9H, Si(CH3)3).

tert-Butyl benzyl(3-(trimethylsilyl)prop-2-yn-1-yl)carbamate (A32)

This compound was prepared with modification to the procedure by Caruso et al.17 An
oven-dried 50-mL round-bottom flask was equipped with a magnetic stir bar, rubber septum,
and nitrogen inlet needle. The flask was flushed with nitrogen. The flask was charged with
the A11 (207 mg, 1 mmol) and anhydrous dimethylformamid (3 mL). Sodium iodide (150 mg,
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1 mmol), caesium carbonate (391 mg, 1.2 mmol), and copper(I) iodide (190 mg, 1 mmol)
were added, and the reaction mixture was allowed to stir at room temperature for 25 min.
3-Trimethylsilylpropargyl bromide (267 mg, 1.4 mmol) was then added dropwise in 1 min.
The reaction mixture was allowed to stir at room temperature for 16 h. The reaction mixture
was diluted with diethyl ether (20 mL) and a solution of saturated ammonium chloride (5
mL). The organic layer was extracted with diethyl ether (2 x 15 mL). The combined organic
layers were washed with brine (15 mL), dried with magnesium sulfate, filtered, and
concentrated under reduced pressure. The crude product was purified by flash column
chromatography (hexane:ethyl acetate = 19:1) to yield product. (127 mg, 40% yield) 1H
NMR (400 MHz, CDCl3): δ 7.31 (m, 5H, ArH), 4.32 (d, J = 6.0 Hz, 2H, CH2Ph), 3.70 (s, 2H,
CH2), 1.46 (s, 9H, C(CH3)3), 0.16 (s, 9H, Si(CH3)3).
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Appendix B: Spectra
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